{"taxa": [{"scientific_name": "cinnamomum verum j. presl", "compounds": ["benzaldehyde", "cinnamyl acetate", "syringic acid", "glucose", "anhydrocinnzeylanin", "l-borneol", "eugenol", "pentacyclic diterpenes", "caryophyllene oxide", "cinnamaldehyde", "a-thujene", "vanillic acid", "arabinose", "benzoic acid", "\u03b2-sitosterol", "\u00df-caryophyllene", "xylanose", "piperitone", "e-nerolidol", "benzyl cinnamate", "a-terpineol", "cinnamic acid", "xylose", "mucilage polysaccharides", "protocatechuic acid", "terpinolene", "benzyl isoquinoline alkaloids", "cinnzeylanine", "flavanol glucosides", "cinncassiols", "a-cubebene", "oligopolymeric procyanidins", "mannitol", "linalool", "coumarin", "anhydrocinnzeylanol", "phenolic acids", "cinnzeylanol", "l-bornyl acetate"], "accepted_name": "Cinnamomum verum", "accepted_species": "Cinnamomum verum", "accepted_genus": "Cinnamomum", "inchi_keys": {"benzaldehyde": "HUMNYLRZRPPJDN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "syringic acid": "JMSVCTWVEWCHDZ-UHFFFAOYSA-N", "glucose": "WQZGKKKJIJFFOK-GASJEMHNSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N", "caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "vanillic acid": "WKOLLVMJNQIZCI-UHFFFAOYSA-N", "arabinose": "SRBFZHDQGSBBOR-HWQSCIPKSA-N", "benzoic acid": "WPYMKLBDIGXBTP-UHFFFAOYSA-N", "\u03b2-sitosterol": "KZJWDPNRJALLNS-VJSFXXLFSA-N", "piperitone": "YSTPAHQEHQSRJD-UHFFFAOYSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "benzyl cinnamate": "NGHOLYJTSCBCGC-VAWYXSNFSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamic acid": "WBYWAXJHAXSJNI-VOTSOKGWSA-N", "xylose": "SRBFZHDQGSBBOR-IOVATXLUSA-N", "protocatechuic acid": "YQUVCSBJEUQKSH-UHFFFAOYSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "cinnzeylanine": "DFYFOAFKHRTQLA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "linalool": "CDOSHBSSFJOMGT-UHFFFAOYSA-N", "coumarin": "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT-UHFFFAOYSA-N", "cinnzeylanol": "TVHZPQAYPSOHQT-AEOFTGFYSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N"}, "inchi_key_simps": {"benzaldehyde": "HUMNYLRZRPPJDN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "syringic acid": "JMSVCTWVEWCHDZ", "glucose": "WQZGKKKJIJFFOK", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO", "caryophyllene oxide": "NVEQFIOZRFFVFW", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "vanillic acid": "WKOLLVMJNQIZCI", "arabinose": "SRBFZHDQGSBBOR", "benzoic acid": "WPYMKLBDIGXBTP", "\u03b2-sitosterol": "KZJWDPNRJALLNS", "piperitone": "YSTPAHQEHQSRJD", "e-nerolidol": "FQTLCLSUCSAZDY", "benzyl cinnamate": "NGHOLYJTSCBCGC", "a-terpineol": "WUOACPNHFRMFPN", "cinnamic acid": "WBYWAXJHAXSJNI", "xylose": "SRBFZHDQGSBBOR", "protocatechuic acid": "YQUVCSBJEUQKSH", "terpinolene": "MOYAFQVGZZPNRA", "cinnzeylanine": "DFYFOAFKHRTQLA", "a-cubebene": "XUEHVOLRMXNRKQ", "linalool": "CDOSHBSSFJOMGT", "coumarin": "ZYGHJZDHTFUPRJ", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT", "cinnzeylanol": "TVHZPQAYPSOHQT", "l-bornyl acetate": "KGEKLUUHTZCSIP"}}, {"scientific_name": "cinnamomum cassia (l.) j. presl", "compounds": ["cinnamyl acetate", "syringic acid", "glucose", "anhydrocinnzeylanin", "l-borneol", "eugenol", "pentacyclic diterpenes", "caryophyllene oxide", "cinnamaldehyde", "a-thujene", "vanillic acid", "arabinose", "\u03b2-sitosterol", "\u00df-caryophyllene", "xylanose", "e-nerolidol", "a-terpineol", "cinnamic acid", "xylose", "mucilage polysaccharides", "protocatechuic acid", "terpinolene", "benzyl isoquinoline alkaloids", "cinnzeylanine", "flavanol glucosides", "cinncassiols", "a-cubebene", "oligopolymeric procyanidins", "mannitol", "coumarin", "anhydrocinnzeylanol", "phenolic acids", "cinnzeylanol", "l-bornyl acetate"], "accepted_name": "Neolitsea cassia", "accepted_species": "Neolitsea cassia", "accepted_genus": "Neolitsea", "inchi_keys": {"cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "syringic acid": "JMSVCTWVEWCHDZ-UHFFFAOYSA-N", "glucose": "WQZGKKKJIJFFOK-GASJEMHNSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N", "caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "vanillic acid": "WKOLLVMJNQIZCI-UHFFFAOYSA-N", "arabinose": "SRBFZHDQGSBBOR-HWQSCIPKSA-N", "\u03b2-sitosterol": "KZJWDPNRJALLNS-VJSFXXLFSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamic acid": "WBYWAXJHAXSJNI-VOTSOKGWSA-N", "xylose": "SRBFZHDQGSBBOR-IOVATXLUSA-N", "protocatechuic acid": "YQUVCSBJEUQKSH-UHFFFAOYSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "cinnzeylanine": "DFYFOAFKHRTQLA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "coumarin": "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT-UHFFFAOYSA-N", "cinnzeylanol": "TVHZPQAYPSOHQT-AEOFTGFYSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N"}, "inchi_key_simps": {"cinnamyl acetate": "WJSDHUCWMSHDCR", "syringic acid": "JMSVCTWVEWCHDZ", "glucose": "WQZGKKKJIJFFOK", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO", "caryophyllene oxide": "NVEQFIOZRFFVFW", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "vanillic acid": "WKOLLVMJNQIZCI", "arabinose": "SRBFZHDQGSBBOR", "\u03b2-sitosterol": "KZJWDPNRJALLNS", "e-nerolidol": "FQTLCLSUCSAZDY", "a-terpineol": "WUOACPNHFRMFPN", "cinnamic acid": "WBYWAXJHAXSJNI", "xylose": "SRBFZHDQGSBBOR", "protocatechuic acid": "YQUVCSBJEUQKSH", "terpinolene": "MOYAFQVGZZPNRA", "cinnzeylanine": "DFYFOAFKHRTQLA", "a-cubebene": "XUEHVOLRMXNRKQ", "coumarin": "ZYGHJZDHTFUPRJ", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT", "cinnzeylanol": "TVHZPQAYPSOHQT", "l-bornyl acetate": "KGEKLUUHTZCSIP"}}, {"scientific_name": "cinnamomum zeylanicum blume", "compounds": ["benzaldehyde", "cinnamyl acetate", "syringic acid", "glucose", "anhydrocinnzeylanin", "l-borneol", "eugenol", "pentacyclic diterpenes", "caryophyllene oxide", "cinnamaldehyde", "a-thujene", "vanillic acid", "arabinose", "benzoic acid", "\u03b2-sitosterol", "\u00df-caryophyllene", "xylanose", "piperitone", "e-nerolidol", "benzyl cinnamate", "a-terpineol", "cinnamic acid", "xylose", "mucilage polysaccharides", "protocatechuic acid", "terpinolene", "benzyl isoquinoline alkaloids", "cinnzeylanine", "flavanol glucosides", "cinncassiols", "a-cubebene", "oligopolymeric procyanidins", "mannitol", "linalool", "coumarin", "anhydrocinnzeylanol", "phenolic acids", "cinnzeylanol", "l-bornyl acetate"], "accepted_name": "Cinnamomum verum", "accepted_species": "Cinnamomum verum", "accepted_genus": "Cinnamomum", "inchi_keys": {"benzaldehyde": "HUMNYLRZRPPJDN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "syringic acid": "JMSVCTWVEWCHDZ-UHFFFAOYSA-N", "glucose": "WQZGKKKJIJFFOK-GASJEMHNSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N", "caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "vanillic acid": "WKOLLVMJNQIZCI-UHFFFAOYSA-N", "arabinose": "SRBFZHDQGSBBOR-HWQSCIPKSA-N", "benzoic acid": "WPYMKLBDIGXBTP-UHFFFAOYSA-N", "\u03b2-sitosterol": "KZJWDPNRJALLNS-VJSFXXLFSA-N", "piperitone": "YSTPAHQEHQSRJD-UHFFFAOYSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "benzyl cinnamate": "NGHOLYJTSCBCGC-VAWYXSNFSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamic acid": "WBYWAXJHAXSJNI-VOTSOKGWSA-N", "xylose": "SRBFZHDQGSBBOR-IOVATXLUSA-N", "protocatechuic acid": "YQUVCSBJEUQKSH-UHFFFAOYSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "cinnzeylanine": "DFYFOAFKHRTQLA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "linalool": "CDOSHBSSFJOMGT-UHFFFAOYSA-N", "coumarin": "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT-UHFFFAOYSA-N", "cinnzeylanol": "TVHZPQAYPSOHQT-AEOFTGFYSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N"}, "inchi_key_simps": {"benzaldehyde": "HUMNYLRZRPPJDN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "syringic acid": "JMSVCTWVEWCHDZ", "glucose": "WQZGKKKJIJFFOK", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO", "caryophyllene oxide": "NVEQFIOZRFFVFW", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "vanillic acid": "WKOLLVMJNQIZCI", "arabinose": "SRBFZHDQGSBBOR", "benzoic acid": "WPYMKLBDIGXBTP", "\u03b2-sitosterol": "KZJWDPNRJALLNS", "piperitone": "YSTPAHQEHQSRJD", "e-nerolidol": "FQTLCLSUCSAZDY", "benzyl cinnamate": "NGHOLYJTSCBCGC", "a-terpineol": "WUOACPNHFRMFPN", "cinnamic acid": "WBYWAXJHAXSJNI", "xylose": "SRBFZHDQGSBBOR", "protocatechuic acid": "YQUVCSBJEUQKSH", "terpinolene": "MOYAFQVGZZPNRA", "cinnzeylanine": "DFYFOAFKHRTQLA", "a-cubebene": "XUEHVOLRMXNRKQ", "linalool": "CDOSHBSSFJOMGT", "coumarin": "ZYGHJZDHTFUPRJ", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT", "cinnzeylanol": "TVHZPQAYPSOHQT", "l-bornyl acetate": "KGEKLUUHTZCSIP"}}, {"scientific_name": "cinnamomum altissimum kosterm", "compounds": ["spathulenol"], "accepted_name": "Cinnamomum altissimum", "accepted_species": "Cinnamomum altissimum", "accepted_genus": "Cinnamomum", "inchi_keys": {"spathulenol": "FRMCCTDTYSRUBE-BGPZULBFSA-N"}, "inchi_key_simps": {"spathulenol": "FRMCCTDTYSRUBE"}}, {"scientific_name": "cinnamomum burmanni (nees & t. nees) blume", "compounds": ["trans-cinnamaldehyde", "eugenol", "coumarin"], "accepted_name": "Cinnamomum burmanni", "accepted_species": "Cinnamomum burmanni", "accepted_genus": "Cinnamomum", "inchi_keys": {"trans-cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N", "coumarin": "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N"}, "inchi_key_simps": {"trans-cinnamaldehyde": "KJPRLNWUNMBNBZ", "eugenol": "RRAFCDWBNXTKKO", "coumarin": "ZYGHJZDHTFUPRJ"}}, {"scientific_name": "cinnamomum iners (reinw. ex nees & t. nees) blume", "compounds": ["caryophyllene oxide", "\u03b1-terpineol", "\u03b2-pinene", "terpinen-4-ol", "1,8-cineole", "\u03b3-terpinolene"], "accepted_name": "Cinnamomum iners", "accepted_species": "Cinnamomum iners", "accepted_genus": "Cinnamomum", "inchi_keys": {"caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "\u03b1-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "\u03b2-pinene": "WTARULDDTDQWMU-UHFFFAOYSA-N", "terpinen-4-ol": "WRYLYDPHFGVWKC-UHFFFAOYSA-N", "1,8-cineole": "WEEGYLXZBRQIMU-UHFFFAOYSA-N"}, "inchi_key_simps": {"caryophyllene oxide": "NVEQFIOZRFFVFW", "\u03b1-terpineol": "WUOACPNHFRMFPN", "\u03b2-pinene": "WTARULDDTDQWMU", "terpinen-4-ol": "WRYLYDPHFGVWKC", "1,8-cineole": "WEEGYLXZBRQIMU"}}, {"scientific_name": "cinnamomum osmophloeum", "compounds": ["caryophyllene oxide", "e-nerolidol", "a-thujene", "a-terpineol", "cinnamyl acetate", "terpinolene", "trans-cinnamaldehyde", "a-cubebene", "l-bornyl acetate", "l-borneol", "\u00df-caryophyllene", "eugenol"], "accepted_name": "Cinnamomum osmophloeum", "accepted_species": "Cinnamomum osmophloeum", "accepted_genus": "Cinnamomum", "inchi_keys": {"caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "trans-cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N"}, "inchi_key_simps": {"caryophyllene oxide": "NVEQFIOZRFFVFW", "e-nerolidol": "FQTLCLSUCSAZDY", "a-thujene": "KQAZVFVOEIRWHN", "a-terpineol": "WUOACPNHFRMFPN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "terpinolene": "MOYAFQVGZZPNRA", "trans-cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-cubebene": "XUEHVOLRMXNRKQ", "l-bornyl acetate": "KGEKLUUHTZCSIP", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO"}}, {"scientific_name": "cinnamomum tamala (buch.-ham.) t. nees & eberm", "compounds": ["cinnamyl acetate", "syringic acid", "glucose", "anhydrocinnzeylanin", "l-borneol", "eugenol", "pentacyclic diterpenes", "caryophyllene oxide", "cinnamaldehyde", "a-thujene", "vanillic acid", "arabinose", "\u03b2-sitosterol", "\u00df-caryophyllene", "xylanose", "e-nerolidol", "a-terpineol", "cinnamic acid", "xylose", "mucilage polysaccharides", "protocatechuic acid", "terpinolene", "benzyl isoquinoline alkaloids", "cinnzeylanine", "flavanol glucosides", "cinncassiols", "a-cubebene", "oligopolymeric procyanidins", "mannitol", "coumarin", "anhydrocinnzeylanol", "phenolic acids", "cinnzeylanol", "l-bornyl acetate"], "accepted_name": "Cinnamomum tamala", "accepted_species": "Cinnamomum tamala", "accepted_genus": "Cinnamomum", "inchi_keys": {"cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "syringic acid": "JMSVCTWVEWCHDZ-UHFFFAOYSA-N", "glucose": "WQZGKKKJIJFFOK-GASJEMHNSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N", "caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "vanillic acid": "WKOLLVMJNQIZCI-UHFFFAOYSA-N", "arabinose": "SRBFZHDQGSBBOR-HWQSCIPKSA-N", "\u03b2-sitosterol": "KZJWDPNRJALLNS-VJSFXXLFSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamic acid": "WBYWAXJHAXSJNI-VOTSOKGWSA-N", "xylose": "SRBFZHDQGSBBOR-IOVATXLUSA-N", "protocatechuic acid": "YQUVCSBJEUQKSH-UHFFFAOYSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "cinnzeylanine": "DFYFOAFKHRTQLA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "coumarin": "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT-UHFFFAOYSA-N", "cinnzeylanol": "TVHZPQAYPSOHQT-AEOFTGFYSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N"}, "inchi_key_simps": {"cinnamyl acetate": "WJSDHUCWMSHDCR", "syringic acid": "JMSVCTWVEWCHDZ", "glucose": "WQZGKKKJIJFFOK", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO", "caryophyllene oxide": "NVEQFIOZRFFVFW", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "vanillic acid": "WKOLLVMJNQIZCI", "arabinose": "SRBFZHDQGSBBOR", "\u03b2-sitosterol": "KZJWDPNRJALLNS", "e-nerolidol": "FQTLCLSUCSAZDY", "a-terpineol": "WUOACPNHFRMFPN", "cinnamic acid": "WBYWAXJHAXSJNI", "xylose": "SRBFZHDQGSBBOR", "protocatechuic acid": "YQUVCSBJEUQKSH", "terpinolene": "MOYAFQVGZZPNRA", "cinnzeylanine": "DFYFOAFKHRTQLA", "a-cubebene": "XUEHVOLRMXNRKQ", "coumarin": "ZYGHJZDHTFUPRJ", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT", "cinnzeylanol": "TVHZPQAYPSOHQT", "l-bornyl acetate": "KGEKLUUHTZCSIP"}}, {"scientific_name": "cinnamomum micranthum f. kanehirae (hayata) s. s. ying", "compounds": ["caryophyllene oxide", "e-nerolidol", "cinnamaldehyde", "a-thujene", "a-terpineol", "cinnamyl acetate", "terpinolene", "a-cubebene", "l-bornyl acetate", "l-borneol", "\u00df-caryophyllene", "eugenol"], "accepted_name": "Camphora kanahirae", "accepted_species": "Camphora kanahirae", "accepted_genus": "Camphora", "inchi_keys": {"caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N"}, "inchi_key_simps": {"caryophyllene oxide": "NVEQFIOZRFFVFW", "e-nerolidol": "FQTLCLSUCSAZDY", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "a-terpineol": "WUOACPNHFRMFPN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "terpinolene": "MOYAFQVGZZPNRA", "a-cubebene": "XUEHVOLRMXNRKQ", "l-bornyl acetate": "KGEKLUUHTZCSIP", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO"}}, {"scientific_name": "cinnamomum bejolghota (buch.-ham.) sweet", "compounds": ["caryophyllene oxide", "e-nerolidol", "cinnamaldehyde", "a-thujene", "a-terpineol", "cinnamyl acetate", "terpinolene", "a-cubebene", "l-bornyl acetate", "l-borneol", "\u00df-caryophyllene", "eugenol"], "accepted_name": "Cinnamomum bejolghota", "accepted_species": "Cinnamomum bejolghota", "accepted_genus": "Cinnamomum", "inchi_keys": {"caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N"}, "inchi_key_simps": {"caryophyllene oxide": "NVEQFIOZRFFVFW", "e-nerolidol": "FQTLCLSUCSAZDY", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "a-terpineol": "WUOACPNHFRMFPN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "terpinolene": "MOYAFQVGZZPNRA", "a-cubebene": "XUEHVOLRMXNRKQ", "l-bornyl acetate": "KGEKLUUHTZCSIP", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO"}}, {"scientific_name": "cinnamomum impressicostatum kosterm", "compounds": ["caryophyllene oxide", "e-nerolidol", "cinnamaldehyde", "a-thujene", "a-terpineol", "cinnamyl acetate", "terpinolene", "a-cubebene", "l-bornyl acetate", "l-borneol", "\u00df-caryophyllene", "eugenol"], "accepted_name": "Cinnamomum vimineum", "accepted_species": "Cinnamomum vimineum", "accepted_genus": "Cinnamomum", "inchi_keys": {"caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N"}, "inchi_key_simps": {"caryophyllene oxide": "NVEQFIOZRFFVFW", "e-nerolidol": "FQTLCLSUCSAZDY", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "a-terpineol": "WUOACPNHFRMFPN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "terpinolene": "MOYAFQVGZZPNRA", "a-cubebene": "XUEHVOLRMXNRKQ", "l-bornyl acetate": "KGEKLUUHTZCSIP", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO"}}, {"scientific_name": "cinnamomum chemungianum m. mohanan and a. n. henry", "compounds": ["caryophyllene oxide", "e-nerolidol", "cinnamaldehyde", "a-thujene", "a-terpineol", "cinnamyl acetate", "terpinolene", "a-cubebene", "l-bornyl acetate", "l-borneol", "\u00df-caryophyllene", "eugenol"], "accepted_name": "Cinnamomum chemungianum", "accepted_species": "Cinnamomum chemungianum", "accepted_genus": "Cinnamomum", "inchi_keys": {"caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N"}, "inchi_key_simps": {"caryophyllene oxide": "NVEQFIOZRFFVFW", "e-nerolidol": "FQTLCLSUCSAZDY", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "a-terpineol": "WUOACPNHFRMFPN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "terpinolene": "MOYAFQVGZZPNRA", "a-cubebene": "XUEHVOLRMXNRKQ", "l-bornyl acetate": "KGEKLUUHTZCSIP", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO"}}, {"scientific_name": "cinnamomum porrectum (roxb.) kosterm", "compounds": ["caryophyllene oxide", "e-nerolidol", "cinnamaldehyde", "a-thujene", "a-terpineol", "cinnamyl acetate", "terpinolene", "a-cubebene", "l-bornyl acetate", "l-borneol", "\u00df-caryophyllene", "eugenol"], "accepted_name": "Camphora parthenoxylon", "accepted_species": "Camphora parthenoxylon", "accepted_genus": "Camphora", "inchi_keys": {"caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N"}, "inchi_key_simps": {"caryophyllene oxide": "NVEQFIOZRFFVFW", "e-nerolidol": "FQTLCLSUCSAZDY", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "a-terpineol": "WUOACPNHFRMFPN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "terpinolene": "MOYAFQVGZZPNRA", "a-cubebene": "XUEHVOLRMXNRKQ", "l-bornyl acetate": "KGEKLUUHTZCSIP", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO"}}, {"scientific_name": "cinnamomum longepaniculatum", "compounds": ["caryophyllene oxide", "e-nerolidol", "cinnamaldehyde", "a-thujene", "a-terpineol", "cinnamyl acetate", "terpinolene", "a-cubebene", "l-bornyl acetate", "l-borneol", "\u00df-caryophyllene", "eugenol"], "accepted_name": "Camphora longepaniculata", "accepted_species": "Camphora longepaniculata", "accepted_genus": "Camphora", "inchi_keys": {"caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N"}, "inchi_key_simps": {"caryophyllene oxide": "NVEQFIOZRFFVFW", "e-nerolidol": "FQTLCLSUCSAZDY", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "a-terpineol": "WUOACPNHFRMFPN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "terpinolene": "MOYAFQVGZZPNRA", "a-cubebene": "XUEHVOLRMXNRKQ", "l-bornyl acetate": "KGEKLUUHTZCSIP", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO"}}, {"scientific_name": "cinnamomum camphora", "compounds": ["caryophyllene oxide", "e-nerolidol", "cinnamaldehyde", "a-thujene", "a-terpineol", "cinnamyl acetate", "terpinolene", "a-cubebene", "l-bornyl acetate", "l-borneol", "\u00df-caryophyllene", "eugenol"], "accepted_name": "Camphora officinarum", "accepted_species": "Camphora officinarum", "accepted_genus": "Camphora", "inchi_keys": {"caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N"}, "inchi_key_simps": {"caryophyllene oxide": "NVEQFIOZRFFVFW", "e-nerolidol": "FQTLCLSUCSAZDY", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "a-terpineol": "WUOACPNHFRMFPN", "cinnamyl acetate": "WJSDHUCWMSHDCR", "terpinolene": "MOYAFQVGZZPNRA", "a-cubebene": "XUEHVOLRMXNRKQ", "l-bornyl acetate": "KGEKLUUHTZCSIP", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO"}}, {"scientific_name": "cinnamomum subavenium miq", "compounds": ["subamolide b", "subamolide e", "subamolide d", "subamolide a"], "accepted_name": "Cinnamomum subavenium", "accepted_species": "Cinnamomum subavenium", "accepted_genus": "Cinnamomum", "inchi_keys": {"subamolide b": "YLCXJNOKPGBEPM-DPBVHHOFSA-N", "subamolide d": "YGFBEYXVYDNDKK-ZSMUJPCHSA-N", "subamolide a": "YLCXJNOKPGBEPM-NBVPMNRZSA-N"}, "inchi_key_simps": {"subamolide b": "YLCXJNOKPGBEPM", "subamolide d": "YGFBEYXVYDNDKK", "subamolide a": "YLCXJNOKPGBEPM"}}, {"scientific_name": "cinnamomum tenuifolium (makino) sugim", "compounds": ["butanolides"], "accepted_name": "Cinnamomum chekiangense", "accepted_species": "Cinnamomum chekiangense", "accepted_genus": "Cinnamomum", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "cinnamomum kotoense", "compounds": ["butanolides"], "accepted_name": "Cinnamomum kotoense", "accepted_species": "Cinnamomum kotoense", "accepted_genus": "Cinnamomum", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "cinnamomum curvifolium (lam.) nees", "compounds": ["cinnamyl acetate", "syringic acid", "glucose", "anhydrocinnzeylanin", "l-borneol", "eugenol", "pentacyclic diterpenes", "caryophyllene oxide", "cinnamaldehyde", "a-thujene", "vanillic acid", "arabinose", "\u03b2-sitosterol", "\u00df-caryophyllene", "xylanose", "e-nerolidol", "a-terpineol", "cinnamic acid", "xylose", "mucilage polysaccharides", "protocatechuic acid", "terpinolene", "benzyl isoquinoline alkaloids", "cinnzeylanine", "flavanol glucosides", "cinncassiols", "a-cubebene", "oligopolymeric procyanidins", "mannitol", "coumarin", "anhydrocinnzeylanol", "phenolic acids", "cinnzeylanol", "l-bornyl acetate"], "accepted_name": "Cinnamomum curvifolium", "accepted_species": "Cinnamomum curvifolium", "accepted_genus": "Cinnamomum", "inchi_keys": {"cinnamyl acetate": "WJSDHUCWMSHDCR-VMPITWQZSA-N", "syringic acid": "JMSVCTWVEWCHDZ-UHFFFAOYSA-N", "glucose": "WQZGKKKJIJFFOK-GASJEMHNSA-N", "l-borneol": "DTGKSKDOIYIVQL-QXFUBDJGSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N", "caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N", "cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "a-thujene": "KQAZVFVOEIRWHN-UWVGGRQHSA-N", "vanillic acid": "WKOLLVMJNQIZCI-UHFFFAOYSA-N", "arabinose": "SRBFZHDQGSBBOR-HWQSCIPKSA-N", "\u03b2-sitosterol": "KZJWDPNRJALLNS-VJSFXXLFSA-N", "e-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "a-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "cinnamic acid": "WBYWAXJHAXSJNI-VOTSOKGWSA-N", "xylose": "SRBFZHDQGSBBOR-IOVATXLUSA-N", "protocatechuic acid": "YQUVCSBJEUQKSH-UHFFFAOYSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "cinnzeylanine": "DFYFOAFKHRTQLA-UHFFFAOYSA-N", "a-cubebene": "XUEHVOLRMXNRKQ-KHMAMNHCSA-N", "coumarin": "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT-UHFFFAOYSA-N", "cinnzeylanol": "TVHZPQAYPSOHQT-AEOFTGFYSA-N", "l-bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N"}, "inchi_key_simps": {"cinnamyl acetate": "WJSDHUCWMSHDCR", "syringic acid": "JMSVCTWVEWCHDZ", "glucose": "WQZGKKKJIJFFOK", "l-borneol": "DTGKSKDOIYIVQL", "eugenol": "RRAFCDWBNXTKKO", "caryophyllene oxide": "NVEQFIOZRFFVFW", "cinnamaldehyde": "KJPRLNWUNMBNBZ", "a-thujene": "KQAZVFVOEIRWHN", "vanillic acid": "WKOLLVMJNQIZCI", "arabinose": "SRBFZHDQGSBBOR", "\u03b2-sitosterol": "KZJWDPNRJALLNS", "e-nerolidol": "FQTLCLSUCSAZDY", "a-terpineol": "WUOACPNHFRMFPN", "cinnamic acid": "WBYWAXJHAXSJNI", "xylose": "SRBFZHDQGSBBOR", "protocatechuic acid": "YQUVCSBJEUQKSH", "terpinolene": "MOYAFQVGZZPNRA", "cinnzeylanine": "DFYFOAFKHRTQLA", "a-cubebene": "XUEHVOLRMXNRKQ", "coumarin": "ZYGHJZDHTFUPRJ", "anhydrocinnzeylanol": "JFDHTDLZWVKRQT", "cinnzeylanol": "TVHZPQAYPSOHQT", "l-bornyl acetate": "KGEKLUUHTZCSIP"}}], "text": "Cinnamomum Species: BridgingPhytochemistry Knowledge,Pharmacological Properties andToxicological Safety for HealthBenefitsJavad Sharifi-Rad1,2*, Abhijit Dey3, Niranjan Koirala4, Shabnum Shaheen5,Nasreddine El Omari 6, Bahare Salehi7*, Tamar Goloshvili 8, Nath\u00e1lia Cristina Cirone Silva9,Abdelhakim Bouyahya10*, Sara Vitalini 11, Elena M. Varoni12, Miquel Martorell 13,14*,Anna Abdolshahi15, Anca Oana Docea16, Marcello Iriti 11, Daniela Calina17*,Francisco Les18,19*, V\u00edctor L\u00f3pez18,19 and Constantin Caruntu20,21*1Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, 2Facultad de Medicina,Universidad del Azuay, Cuenca, Ecuador, 3Department of Life Sciences, Presidency University, Kolkata, India, 4Department ofNatural Products Drugs Discovery, Dr. Koirala Research Institute for Biotechnology and Biodiversity, Kathmandu, Nepal,5Department of Botany, Lahore College for Women University, Lahore, Pakistan, 6Laboratory of Histology, Embryology andCytogenetic, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco, 7Medical Ethics and LawResearch Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, 8Institute of Botany, Plant Physiology andGeneticResources, Ilia State University, Tbilisi, Georgia, 9Department of Food Science, Faculty of Food Engineering (FEA), University ofCampinas (UNICAMP), Campinas, Brazil, 10Laboratory of Human Pathology Biology, Faculty of Sciences, Genomic Center ofHuman Pathology, Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Rabat, Morocco, 11Department ofAgricultural and Environmental Sciences, Milan State University, Milan, Italy, 12Department of Biomedical, Surgical and DentalSciences, Milan State University, Milan, Italy, 13Department of Nutrition and Dietetics, Faculty of Pharmacy, University ofConcepcion, Concepcion, Chile, 14Universidad de Concepci\u00f3n, Unidad de Desarrollo Tecnol\u00f3gico, UDT, Concepcion, Chile,15Food Safety Research Center (salt), Semnan University of Medical Sciences, Semnan, Iran, 16Department of Toxicology,University of Medicine and Pharmacy of Craiova, Craiova, Romania, 17Department of Clinical Pharmacy, University of Medicineand Pharmacy of Craiova, Craiova, Romania, 18Department of Pharmacy, Faculty of Health Sciences, Universidad San Jorge,Zaragoza, Spain, 19Instituto Agroalimentario de Arag\u00f3n-IA2 (CITA-Universidad de Zaragoza), Zaragoza, Spain, 20Department ofPhysiology, \"Carol Davila\" University of Medicine and Pharmacy, Bucharest, Romania, 21Department of Dermatology, \"Prof. N.C.Paulescu\" National Institute of Diabetes, Nutrition and Metabolic Diseases, Bucharest, RomaniaThe genus Cinnamomum includes a number of plant species largely used as food, foodadditives and spices for a long time. Different traditional healing systems have used theseplants as herbal remedies to cure diverse ailments. The aim of this comprehensive andupdated review is to summarize the biodiversity of the genus Cinnamomum, its bioactivecompounds, the mechanisms that underlie the pharmacological activities and moleculartargets and toxicological safety. All the data in this review have been collected fromdatabases and recent scientific literature including Web of Science, PubMed,ScienceDirect etc. The results showed that the bioactive compounds of Cinnamomumspecies possess antimicrobial, antidiabetic, antioxidant, anti-inflammatory, anticancer andneuroprotective effects. The preclinical (in vitro/in vivo) studies provided the possiblemolecular mechanisms of these action. As a novelty, recent clinical studies andtoxicological data described in this paper support and confirm the pharmacologicalimportance of the genus Cinnamomum. In conclusion, the obtained results frompreclinical studies and clinical trials, as well as reduced side effects provide insightsEdited by:Thomas Efferth,Johannes Gutenberg UniversityMainz, GermanyReviewed by:Wannee Jiraungkoorskul,Mahidol University, ThailandDeepak Kumar Semwal,Uttarakhand Ayurved University, India*Correspondence:Javad Sharifi-Radjavad.sharifirad@gmail.comBahare Salehibahar.salehi007@gmail.comAbdelhakim Bouyahyaboyahyaa-90@hotmail.frMiquel Martorellmartorellpons@gmail.comDaniela Calinacalinadaniela@gmail.comFrancisco Lesfles@usj.esConstantin Caruntucostin.caruntu@gmail.comSpecialty section:This article was submitted toEthnopharmacology,a section of the journalFrontiers in PharmacologyReceived: 28 August 2020Accepted: 06 April 2021Published: 11 May 2021Citation:Sharifi-Rad J, Dey A, Koirala N,Shaheen S, El Omari N, Salehi B,Goloshvili T, Cirone Silva NC,Bouyahya A, Vitalini S, Varoni EM,Martorell M, Abdolshahi A, Docea AO,Iriti M, Calina D, Les F, L\u00f3pez V andCaruntu C (2021) CinnamomumSpecies: Bridging PhytochemistryKnowledge, PharmacologicalProperties and Toxicological Safety forHealth Benefits.Front. Pharmacol. 12:600139.doi: 10.3389/fphar.2021.600139Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 6001391REVIEWpublished: 11 May 2021doi: 10.3389/fphar.2021.600139into future research of new drugs based on extracts and bioactive compounds fromCinnamomum plants.Keywords: Ciannamomum spp., phytochemistry, Pharmacology, mechanisms of action, clinical trials, ToxicologicaldataINTRODUCTIONThe Cinnamomum plants have been studied for its phyto-constituents and pharmacological properties as well astraditional medicinal significance. Cinnamomum verum,known as the \u201ctrue cinnamon tree\u201d and \u201cCeylon cinnamontree\u201d is an evergreen small, tree that belongs to the Lauraceaefamily. Along with other cinnamon species, such asCinnamomum cassia, Cinnamomum verum etc., the tree barkis used to obtain cinnamon (Ribeiro-Santos et al., 2017). Theancient botanical name of this tree \u2013 Cinnamomum zeylanicum-derives from Ceylon the old name for Sri Lanka (Ribeiro-Santoset al., 2017). Cinnamomum cassia, also called \u201cChinesecinnamon,\u201d is an evergreen tree, native to South China;Chinese cinnamon being produced mainly in the southernregions and is also widely grown in the other areas of theSouth and East Asia (Bedigian, 2005). People used cinnamonobtained from a variety of Cinnamomum plants as a spice fromancient times. It is mentioned in the texts written in Sanskrit andin the Bible, as well as in the works of Herodotus and Pliny (Luet al., 2011). In Egypt, Cinnamomum zeylanicum was used in theembalming process. It was also added to foods for preservation.Both in India and Europe, Cinnamomum species have beentraditionally used in the treatment of respiratory viruses,especially combined with ginger (Zingiber officinale). Gingerstimulates blood circulation in the extremities (toes, fingers),and Cinnamomum plants are an alternative natural medicine forreducing muscle pain and other signs and symptoms of colds andflu. Other traditional uses include urinary tract infections, relievethe abdominal discomfort, and improves digestion, antidiabetic,analgesic, and neuroprotective effects (Ravindran et al., 2003).All types of cinnamon contain the active ingredientcinnamaldehyde, which accounts for between 65 and 80% ofthe essential natural oil. Cinnamon is used in case of dyspepsia,flatulence, nausea, intestinal colic, slow digestion, diarrhea, anddigestive atony. This antispastic effect is attributed to the naturalchemical compound catechin that contributes to the reduction ofnausea and vomiting. Also, its volatile oil can help better foodprocessing by breaking down fat during digestion. The studiesshowed that cinnamon helps diabetic patients to metabolize sugarmore easily. In the case of people with type II diabetes, thepancreas produces insulin, but their body cannot use it effectivelyfor decreasing blood sugar concentration (Chen et al., 2012). Theresearchers have found in recent studies that cinnamon improvesinsulin\u2019s ability to metabolize glucose, helping to control bloodsugar levels. It contains the antioxidant glutathione and a type offlavonoid called methyl hydroxychalcone polymer (MHCP) (Qinet al., 2010). The potential antidiabetic mechanism of cinnamonis associated with increasing the receptivity of adipose cells to thehormone insulin that regulates the metabolism of glucose andcontrols the level of sugar in the blood.Cinnamon helps reduce pain due to its action of inhibitingprostaglandin. Cinnamaldehyde acts against the coagulation ofplatelets in the blood, which can hinder blood flow. It inhibitsarachidonic acid\u2019s release (a trigger for the inflammatoryresponse) from cell membranes (Vallianou et al., 2019).Therefore, cinnamon is useful for the pharmacotherapy ofinflammatory diseases, such as rheumatoid arthritis(Rogoveanu et al., 2018; Shishehbor et al., 2018). Recentstudies showed that the scent and aroma of cinnamon act ascognitive stimuli, which could improve memory, visual-motorcapacity and virtual memory (Nussbaum et al., 2017), due to itscompound cinnamic aldehyde. Experimental researches onrodents receiving cinnamic aldehyde have reportedimprovements in stress-induced depressive behaviors.Cinnamic aldehyde is administered orally in the treatment ofbehavioral and mental disorders. Recent findings in this regardmay also be helpful in treating depression (Panickar et al., 2009).Starting from the ethnopharmacological premises of thetherapeutic beneficial effects of Cinnamomum genus, in thismanuscript were highlighted, based on scientific evidence thepotential current pharmacological mechanisms and humanclinical studies for the benefits of human health. Therefore,this current work reviews the comprehensive and currentknowledge on the phyto-constituents, potential mechanisms ofthe main pharmacological activities evidenced by preclinicalstudies (in vivo, in vitro), recent clinical trials and toxicologicaldata regarding safety of Cinnamomum plants.REVIEW METHODOLOGYScientific search engines Medline, PubMed, ScienceDirect andScopus were searched to retrieve literature and cross-referencesusing key words: \u201cCinnamomum,\u201d \u201cphytochemistry,\u201d\u201cpharmacology\u201d; \u201cmechanisms of action\u201d; \u201ctoxicology.\u201d Weincluded literature in relation to the bioactive compounds,pharmacological activities and underlying mechanism ofaction, clinical studies, toxicological and safety considerationsof different Cinnamomum species. Plants\u2019 taxonomy wasvalidated using The Plant List (http://www.theplantlist.org/),and chemical formulas were validated by consulting thePubChem chemical base data (http://pubchem.ncbi.nlm.nih.gov/search/#collection\u0001compounds). Inclusion criteria:in vitro/in vivo pharmacological studies using cell lines andlaboratory animals, studies involving extracts of the genusCinnamomum, studies with obvious mechanisms of action.Exclusion criteria: studies that included homeopathicFrontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 6001392Sharifi-Rad et al. Cinnamomum Speciespreparations and other associated nutritional supplements,studies without explaining the mechanism of action.PHYTOCHEMISTRY OF CINNAMOMUMGENUSChemical CompositionThe chemical composition of cinnamon EOs (essential oils)varies depending on several factors that include the part of theplant used, growing season, age of trees, location, and extractionmethods (Kaul et al., 2003; Barceloux, 2009; Wang et al., 2009;Chakraborty et al., 2015). Cinnamaldehyde and its analogs,butanolides, diterpenoids, lignans and several othercompounds, are present in this genus. From the genusCinnamomum, a total of 127 chemical compounds have beenidentified (Zhao and Ma, 2016).Cinnamon presents a diversity of resinous compounds,including cinnamaldehyde, cinnamates, cinnamic acid andnatural EOs (Senanayake et al., 1978) (Figure 1; Table 1).Over time, cinnamaldehyde changes color, absorbs oxygen andthus explains the appearance of the perfume and spicy taste(Singh et al., 2007). EOs contain a great variety of volatile naturalcompounds, such as trans-cinnamaldehyde, eugenol, cinnamylacetate, L-borneol, \u00df-caryophyllene, caryophyllene oxide,L-bornyl acetate, a-thujene, a-terpineol, a-cubebene,terpinolene and E-nerolidol (Jantan and Goh, 1992; Jantanet al., 2003; Jantan et al., 2005; Chua et al., 2008; AbdelwahabFIGURE 1 | Chemical structures of the phyto-constituents of Cinnamomum species.Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 6001393Sharifi-Rad et al. Cinnamomum Specieset al., 2010; Tung et al., 2010; Geng et al., 2011). Spathulenol wasreported as the major compound in leaf oil of Cinnamomumaltissimum Kosterm (Jantan et al., 2003).According to (Wang et al., 2009), eugenol (80%) is the mainvolatile compound in the EO of Cinnamomum verum J. Presl(synonym: Cinnamomum zeylanicum Blume) instead of trans-cinnamaldehyde (16.25%) and the other constituents such as:alcohols, aldehydes, ketones, alkanes, sulfides, and ethers. Thechemical composition in the bark and leaf EOs of C. verumconsists of high levels of eugenol (90.2%) and cinnamaldehyde(44.2%). The chemical constituents of C. verum bark EO includethree major compounds and six minor chemical derivatives(Yang et al., 2012). Cinnamaldehyde (59%), benzaldehyde(12%) and eugenol (5%) are the major compounds, while thesix minor constituents are \u03b1-phellandrene (1.1%), linalool (1.1%),benzoic acid (0.8%), \u03b2-caryophyllene (0.7%), linalyl acetate(0.6%) and benzyl cinnamate (0.6%). The most importantcompounds identified in the leaf oil of C. verum grown areeugenol (75%), linalool (8%) and piperitone (2.5%) (Rainaet al., 2001).Chemical constituents in the leaf EO of Cinnamomumburmanni (Nees & T. Nees) Blume are trans-cinnamaldehyde(60%), eugenol (18%) and coumarin (14%). Other constituentsidentified in the oils are alcohols, aldehydes, and ketones. Themajor components in the stem bark oil of Cinnamomum iners(Reinw. ex Nees & T. Nees) Blume are 1,8-cineole (41%),\u03b1-terpineol (15%) and terpinen-4-ol (14%). The othercomponents identified are \u03b2-pinene (4.75%), \u03b3-terpinolene(1.61%) and caryophyllene oxide (4.37%) (Wang et al., 2009).Other minor constituents reported in cinnamon EO include:cinnamic acid, phenolic acids, oligopolymeric procyanidins,pentacyclic diterpenes, cinnzeylanol, and its acetyl derivativecinnzeylanine, mannitol, xylose, arabinose, xylanose, glucose, mucilagepolysaccharides (European Scientific Cooperative on Phytotherapy,2003). Several nonvolatile compounds have been found in cinnamonEOs such as cinncassiols, cinnzeylanol, cinnzeylanin,anhydrocinnzeylanol, anhydrocinnzeylanin, several benzyl isoquinolinealkaloids, cinnamic acid, \u03b2-sitosterol, flavanol glucosides, coumarin,protocatechuic acid, vanillic acid and syringic acid (Leela, 2008).Cinnamomum\u2019s Natural Compounds:Pharmacokinetics, Bioavailability,Bioactivity and MetabolismConsidering the pharmacokinetics, bioavailability andmetabolism of Cinnamomum active ingredients, very littleworks have been performed. Many studies described the roleof bioactive compounds from the plants in enhancingbioavailability of some standard drugs (Salehi et al., 2020b).Pharmacokinetics of cinnamic acid (CA) indicated the CAwasreadily absorbed and then metabolized quickly into hippuric acid(HA) when a decoction of Ramulus Cinnamomi (RC) [containingCA 7.62 \u00d7 10\u20135 mol/kg and cinnamaldehyde (CNMA) 1.77 \u00d710\u20135 mol/kg] was administered in rats via oral route. CNMA wasfound to be metabolized partially in stomach and small intestineinto CA and almost fully metabolized in liver into CA beforebeing absorbed into rat blood. The results indicated that plasmaCA in RC group probably came from CNMA transformation inRC (Chen et al., 2009). Cinnamon also increased pioglitazonebioavailability via CYP3A4 enzyme inhibition in rat followingoral administration owing to its possible use in combination withpioglitazone against diabetes (Mamindla et al., 2017). CAsignificantly inhibited rosuvastatin (RSV) (a specific breastcancer resistance protein) transport into rat bile thusenhanced the plasma exposure of the same (Basu et al., 2013).In a recent study, comparative pharmacokinetic analysis ofCinnamomum cassia twigs\u2019 standard decoction and dispensinggranules containing three phenolics such as cinnamic acid,vanillic acid and protocatechuic acid in rats revealed theAUC0\u2013t values of the compounds by LC\u2013MS/MS (Tao et al.,2019).PRECLINICAL STUDIES RELATED TOPHARMACOLOGICAL ACTIVITIES ANDPOTENTIAL MECHANISMS OFCINNAMOMUM\u2019S PHYTO-CONSTITUENTSVarious traditional uses of Cinnamomum plants motivated aseries of experimental investigations of the plant\u2019spharmacological properties (Wang et al., 2020). Thoseexperimental approaches tempted to validate the potential usesof these plants as therapeutic remedies. Studies have beenreported on extracts and isolated compounds of Cinnamomumplants, investigating antibacterial, anti-diabetes, anti-inflammatory, antioxidant, antitumor, and neuroprotectiveproperties.Antibacterial ActivityIn order to inhibit the growth and proliferation of pathogenicmicroorganisms, synthetic drugs have been commonly used forTABLE 1 | The most representative chemical compounds of Cinnamomum plants.Plant parts Compounds RefBark cinnamaldehyde 65\u201380% eugenol 5\u201310% Yanakiev. (2020)Bark of root camphor 58% Rao and Gan. (2014)Leaf eugenol 70\u201390%, cinnamaldehyde 1\u20138% Utchariyakiat et al. (2016)Fruits trans-cinnamyl acetate 40\u201350% caryophyllene 10\u201315% Bakar et al. (2020)Buds \u03b1-bergamotene 27% terpene hydrocarbons 80% \u03b1-copaene 20%, terpenoids 10% Barceloux. (2009)Flowers trans-cinnamyl acetate 40% trans-\u03b1-bergamotene 10% caryophylleneoxide 8% Bakar et al. (2020)Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 6001394Sharifi-Rad et al. Cinnamomum Speciesthe treatment of microbial infections. The overuse ofconventional antibacterial drugs could lead to serious sideeffects, including the selection of resistant bacterial strains andthe development of antibiotic resistance during treatment, posinga real threat to global public health (Russell, 2002; Goyal et al.,2008; Ca\u0306lina et al., 2017; Ungureanu et al., 2017; Zlatian et al.,2018). Therefore, it is necessary to discover new sources ofantibiotics such us natural antimicrobial compounds thatcould be an effective and cheaper alternative (Mbwambo et al.,2007; Salehi et al., 2019a).The mechanisms underlying the antibacterial effects of naturalderivatives of Cinnamomum plants are complex.Cinnamaldehyde, as well as eugenol, inhibited \u03b2-lactamase\u2019sproduction by the bacterium and destroyed its cell wall(Helander et al., 1998; Di Pasqua et al., 2007). Phenoliccompounds such as carvacrol can also cause destruction of thecell cytoplasmic membrane (Ultee et al., 1999), and terpenesinteract with the bacterial membrane by modifying itspermeability (Lambert et al., 2001) and increasing thepenetration of antibacterial agents. Essential oils ofCinnamomum contain a wide range of different groups ofchemical compounds, suggesting that their antibacterialactivity might have several mechanisms (Skandamis andNychas, 2001; Carson et al., 2002). (Figure 2).A recent study highlighted that MBC (minimum bactericidalconcentration) and MIC (minimum inhibitory concentration) ofthe methanol extract of C. burmanni leaves were 625 and2,500 \u03bcg/ml, against Bacillus cereus. For other bacterial strains(Staphilococcus aureus, Listeria monocytogenes, Escherichia coli,and Salmonella anatum), the values are >2,500 \u03bcg/ml for bothconcentrations (Shan et al., 2007).The methanol extract of Cinnamomum tamala (Buch.-Ham.)T. Nees & Eberm. stem bark revealed MIC values of 256, 4,096,4,096, and 2048 \u03bcg/ml against Staphilococcus aureus,Streptococcus pyogenes, B. cereus and Bacillus subtilis,respectively, with inhibition diameters ranging from 14.0 to20.8 mm (Goyal et al., 2009). The aqueous extract of C. verumbark demonstrated antibacterial activity against Moraxellacattarhalis with MIC and MBC values of 120 and 240 mg/ml,respectively, and an inhibition zone of 11 mm (Rasheed andThajuddin, 2011). (Table 2).Regarding the EO of C. osmophloeum leaves, the MIC valueswere 200 and 500 \u03bcg/ml for the 9 bacteria tested (Chang et al.,2001), and the chemical components of this oil were similar toFIGURE 2 | Antibacterial properties of Cinnamomum plants\u2019 derivatives. The main potential mechanisms of antibacterial action are related to: 1) the partialdegradation of the bacterial cell wall, 2) the increase of membrane permeability, 3) the leakage of cytoplasm materials, 4) the shrinkage of bacterial cells and prominentdistortion, and 5) the alteration of secondary, tertiary structures and bacterial protein.Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 6001395Sharifi-Rad et al. Cinnamomum Speciesthose of Cinnamomum cassia (L.) J. Presl (Hu et al., 1985). Inaddition, (Oussalah et al., 2006) evaluated the antibacterialefficacy of essential oils of two Cinnamomum species: C. cassiand C. verum against Pseudomonas putida and found MIC valuesof 0.05 and 0.1 % wt/vol, respectively. In another study, the MICvalues for the EO of C. cassia leaves were 500 ppm for E. coli, B.cereus, Lactobacillus sakei and 750 mg/ml for Salmonellatyphimurium (Turgis et al., 2012).The antibacterial potency of the methanol extract of C. cassiawas also tested against different species of E. coli by the diskdiffusion method and the microdilution (Kim et al., 2004). The C.cassia bark EO was tested on L. monocytogenes and EPEC with azone of inhibition of 22.42 and 13.72 mm, respectively, and aMICof 0.03 and 0.06 \u03bcg/ml respectively (de Oliveira et al., 2012).Another study on the same part of C. cassia investigated thepermeability of the bacterial membrane by measuring the relativeelectrical conductivity, which increased with the increasedconcentration of the EO (Huang et al., 2014).The antimicrobial property of C. verum EO was assayedagainst 21 bacteria strains, using MIC methods and discdiffusion. The EO highlighted the significant antibacterialactivity against the tested strains. It showed higher activityagainst Gram-positive (Enterococcus, Streptococcus,Staphylococcus) and Gram-negative (Pseudomonas aeruginosa)bacteria strains. These results are consistent with those of Chaoet al. (2000) revealing that bark oil of cinnamon completelyinhibited the growth of selected Gram-negative and Gram-positive bacteria.In vitro antibacterial efficacy of different EOs (Al-Bayati andMohammed, 2009; Noudeh et al., 2010; Guerra et al., 2012;Utchariyakiat et al., 2016) and methanol extracts (Hameedet al., 2016) of C. verum bark was evaluated against Gram-positive and Gram-negative bacteria using broth dilution anddiffusion methods. The obtained results showed that C. verumwas able to inhibit all of the tested strains. Furthermore, the mainchemical constituents of C. cassia and C. verum natural oils wereeugenol cinnamaldehyde (Ross, 1976; Hu et al., 1985) whichcould inhibit microbial growth (Lee and Ahn, 1998; Ooi et al.,2006).EOs of Cinnamomum micranthum f. kanehirae (Hayata) S. S.Ying (leaves and twigs) were effective against Vibrioparahemolyticus, V. alginolyticus, V. vulnificus, Lactococcusgarvieae, Debaryomyces hansenii, Photobacteria damsel,Streptococcus sp. and Aeromonas hydrophila, with diametersreduction from 0.1 to 1 cm (Yeh et al., 2009). The observeddifference may be due to the difference of antibacterialconstituents in leaves and twigs. The antibacterial screening ofEO samples extracted from Cinnamomum bejolghota (Buch.-Ham). Sweet was evaluated using disc diffusion assay againstzoonotic enteropathogens and showed promising antibacterialactivity (Wannissorn et al., 2005). Indeed, EOs are complexes ofantibacterial agents including natural aromatic and volatilecompounds (Loy et al., 2001).The volatile oils and extracts from the stem bark ofCinnamomum impressicostatum Kosterm., C. altissimum andC. porrectum (Roxb.) Kosterm showed high antibacterialactivity against Gram-positive and Gram-negative bacteria,including methicillin-resistant Staphylococcus aureus (MRSA).Some tested extracts exhibited relevant activity against MRSAcompared with methicillin-sensitive S. aureus (MSSA). Thehighest inhibition zone (21.0 mm) was measured for C.impressicostatum stem-bark water extract against MRSA withMIC and MBC values of 19.5 and 39.0 \u03bcg/ml, respectively (Buruet al., 2014). The leaf oil of Cinnamomum chemungianum M.Mohanan and A. N. Henry enhanced a moderate activity againstthe tested bacteria (Rameshkumar et al., 2007).Agarwal et al. (2019) used C. tamala leaf extract to synthesizeeco-friendly zinc oxide nanoparticles with importantantibacterial effects against S. aureus. Authors showed thatthese nanoparticles induced reduction in bacterial growth, in atime and concentration-dependent pattern, due to membranedamage that leads to leakage of intracellular proteins and cellularcontents. On the other hand, C. verum EOs exhibited remarkableinhibitory effects of Staphylococcus aureus multi-drugresistant (MDR). Indeed, cinnamon oil at concentrationsof 3.12% strongly inhibited all the Streptococcus mutansisolated with the MIC values of 12.8\u201351.2 and 64\u2013256 mg/ml, respectively (Fani and Kohanteb, 2011). (Rossi et al.,2019) showed that C. verum EOs inhibited the adhesion ofSalmonella enterica which involved the reduction ofpolyphenol oxidase activity. (Wu et al., 2019) showed thatC. camphora EOs had an important antibacterial potencyagainst E. coli with a MIC and MBC of 200 \u03bcg/L.(Yap et al., 2015) have studied the EO of C. verum bark againstE. coli by testing the permeability of its outer membrane, and theyfound that the observed membrane damage was determined bydenaturation and acidification of the cell membrane (Borges et al.,2013). This suggested that the EO of C. verum bark disrupts thecell membrane at lethal and sub-lethal concentrations byincreasing the availability of the antibiotic in the bacterial cell(Eumkeb et al., 2012). Indeed, EOs are complexes of antibacterialagents including natural aromatic and volatile compounds (Loyet al., 2001).Antidiabetic ActivitiesDiabetes mellitus is a chronic disease that affects about 7% of theworld\u2019s people (Zimmet et al., 2001) and it is expected to increaseby 5.5% in 2025 (King et al., 1998). Diabetes mellitus type 2(T2DM) accounts for 85\u201390% of all diagnosed diabetic patients(Wild et al., 2004) with high medical and social costs. Diabetesmellitus is characterized by an altered metabolism (ofcarbohydrates, lipids, and lipoproteins) and chronichyperglycemia resulting from pancreatic \u03b2-cell dysfunction(Wild et al., 2004; Qin et al., 2010), insulin productiondeficiency, insulin resistance in key target tissues and impairedglycemic index control (Leiter and Lewanczuk, 2005), (DeFronzoet al., 1992). These alterations cause severe complications in thefunctioning of the cardiovascular system, as well as hypertensionand dyslipidemia that are risk factors for stroke and myocardialinfarction (Luscher and Steffel, 2008). Postprandial glucosecontrol is essential for treating diabetes mellitus and avoidingits complications (Ortiz-Andrade et al., 2007). Moreover, correctdiet and sport are necessary for the prevention of T2DM (Kahnet al., 2006; Hu, 2011).Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 6001396Sharifi-Rad et al. Cinnamomum SpeciesTABLE 2 | Preclinical pharmacological activities of Cinnamomum genus.PharmacologicalactivityCinnamum plant/extracts/fractionsMethods Models cellular lines(in vitro)/animal (in vivo)Effects/underlyingmechanismsRefAntimicrobial Cinnamomum altissimum/stembark/EOsDisk diffusion MRSA IC50 \u0001 12.0 mm Buru et al. (2014)\u2193bacterial growthMicrodilution MRSA IC50 \u0001 156.25 \u03bcg/ml\u2193 bacterial growthCinnamom umbejolghota/leaves/EOs Disk diffusion Escherichia coli 19.5 mm Wannissorn et al. (2005)Salmonella saintpaul 17.5 mmSalmonella derby 16.5 mmSalmonella gallinarum 34 mmSalmonella schwarzergrund 16.5 mmSalmonella mbandaka 18 mmSalmonella monterideo 16.5 mmCinnamom umburmanni Leaves/EOs Microdilution Staphylococcus aureus IC50 > 2,500 \u03bcg/ml Shan et al. (2007)Listeria monocytogenes IC50 > 2,500 \u03bcg/mlSalmonella anatum IC50 > 2,500 \u03bcg/mlEscherichia coli IC50 > 2,500 \u03bcg/mlCinnamomum cassia leaves/EOs Microdilution Pseudomonas putida IC50 \u0001 500 mg/L Oussalah et al. (2006)Cinnamomum cassia leaves/EOs Microdilution Bacillus cereus IC50 \u0001 500 mg/L Turgis et al. (2012)Escherichia coli IC50 \u0001 500 mg/L notdeterminedStaphylococcus aureusCinnamomum cassia/shoots/methanolDisk diffusion Escherichia coli 13 mm Kim et al. (2004)Microdilution IC50 \u0001 250\u2013500 \u03bcg/mlCinnamomum cassia bark/EOs Disk diffusion Listeria monocytogenes 22.4 mm de Oliveira et al. (2012)Microdilution IC50 \u0001 0.03 \u03bcg/mlAgar disc diffusion Bacillus subtilis 21.1 mm (Huang et al., 2014)Salmonella typhimurium 14.5 mmStaphylococcus aureus 27.5 mmMicrodilution Staphylococcus aureus IC50 \u0001 2.5\u20135 mg/mlMicrodilution assay Bacillus subtilis IC50 \u0001 10 mg/mlSalmonella typhimurium IC50 \u0001 20 mg/mlEscherichia coli IC50 \u0001 10 mg/mlPermeability of cellmembraneStaphylococcus aureus \u2191 permeability of wall cellEscherichia coliCinnamomum chemungianumleaves/EOsDisk diffusion Staphylococcus aureus 7 mm Rameshkumar et al.(2007)Bacillus subtilis 8 mmSalmonella typhi 9 mmEscherichia coli 12 mmPseudomonas fluorescens 7 mmProteus vulgaris 7 mmKlebsiella pneumoniae 11 mmCinnamomumim pressicostatum stembark/VODisk diffusion MRSA 14.5 mm Buru et al. (2014)Microdilution IC50 \u0001 156.3 \u03bcg/mlCinnamomum iners stem bark/VO Disk diffusion MRSA 10.5 mm Buru et al. (2014)Microdilution IC50 \u0001 625.0 \u03bcg/mlCinnamomum longepaniculatumleaves/VOMicrodilution Escherichia coli IC50 \u0001 3.1 \u03bcL/ml Li et al. (2014)Salmonella enteritidis IC50 \u0001 6.3 \u03bcL/mlStaphylococcus aureus IC50 \u0001 6.3 \u03bcL/mlCinnamomummicranthum leaves/EOs Diffusion method Vibrio parahemolyticus 2 mm Yeh et al. (2009)Vibrio alginolyticus 3 mmVibrio alginolyticus 3 mmVibrio vulnificus 2 mmLactococcus garvieae 1 mmDebaryomyces hansenii 1 mmPhotobacteria damsel 1 mmStreptococcus sp 1 mmEromonas hydrophila 2 mmCinnamomum micranthum twig/EOs Diffusion method Vibrio parahemolyticus 5 mmVibrio alginolyticus 5 mmVibrio alginolyticus 6 mmVibrio vulnificus 5 mmLactococcusgarvieae 3 mmDebaryomyces hansenii 4 mmPhotobacteria damsel 7 mmStreptococcus sp 7 mmEromonas hydrophila 1 mmCinnamomum osmophloeumleaves/EOsMicrodilution Escherichia coli IC50 \u0001 250 \u03bcg/ml Chang et al. (2001),Chang et al. (2008)Enterococcus faecalis IC50 \u0001 250 \u03bcg/mlKlebsiella pneumoniae IC50 \u0001 500 \u03bcg/ml(Continued on following page)Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 6001397Sharifi-Rad et al. Cinnamomum SpeciesTABLE 2 | (Continued) Preclinical pharmacological activities of Cinnamomum genus.PharmacologicalactivityCinnamum plant/extracts/fractionsMethods Models cellular lines(in vitro)/animal (in vivo)Effects/underlyingmechanismsRefSalmonella sp IC50 \u0001 500 \u03bcg/mlVibrio parahemolyticus IC50 \u0001 250 \u03bcg/mlStaphylococcus epidermidis IC50 \u0001 250 \u03bcg/mlMRSA IC50 \u0001 250 \u03bcg/mlLegionella pneumophila IC50 \u0001 1,000 \u03bcg/mlCinnamomum porrectum stembark/VODisk diffusion MRSA 7.5 mm Buru et al. (2014)Microdilution IC50 \u0001 500 \u03bcg/mlCinnamomum tamala stem bark/methanolic extractAgar well diffusion Escherichia coli Without inhibition Goyal et al. (2009)Salmonella typhi 11 mmBacillus cereus 14 mmBacillus subtilis 14 mmStaphylococcus aureus 20 mmStreptococcus pyogenes 13.5 mmStaphylococcus aureus IC50 \u0001 256 \u03bcg/mlStreptococcus pyogenes IC50 \u0001 4,096 \u03bcg/mlBacillus subtilis IC50 \u0001 4,096 \u03bcg/mlCinnamomum verum bark/EOs Microdilution Staphylococcus aureus IC50 \u0001 0.55 mg/ml Unlu et al. (2010)Streptococcus pyogenes IC50 \u0001 0.55 mg/mlStreptococcus pneumoniae IC50 < 0.04 mg/mlEnterococcus faecalis IC50 \u0001 1.15 mg/mlEnterococcus faecium IC50 \u0001 1.12 mg/mlBacillus cereus IC50 \u0001 0.56 mg/mlAcinetobacter lwoffii IC50 < 0.04 mg/mlEnterobacter erogenes IC50 \u0001 0.56 mg/mlEscherichia coli IC50 \u0001 1.12 mg/mlKlebsiella pneumoniae IC50 \u0001 0.14 mg/mlProteus mirabilis IC50 \u0001 0.14 mg/mlPseudomonas eruginosa IC50 \u0001 0.28 mg/mlSalmonella typhimurium IC50 \u0001 0.14 mg/mlMycobacterium smegmatis IC50 \u0001 0.07 mg/mlClostridium perfringens IC50 \u0001 0.14 mg/mlListeria ivanovii IC50 \u0001 0.56 mg/mlListeria innocua IC50 \u0001 0.28 mg/mlListeria welshimeri IC50 \u0001 0.56 mg/mlListeria seeligeri IC50 \u0001 0.56 mg/mlCinnamomum verum bark/aqueous Disk diffusion Moraxella cattarhalis 11 mm Rasheed and Thajuddin.(2011)Microdilution Moraxella cattarhalis IC50 \u0001 120 mg/mlCinnamomum verum bark/EOs Microdilution Pseudomonas eruginosa IC50 \u0001 0.1125 mg/ml Utchariyakiat et al. (2016)Cinnamomum verum bark/methanolic Disk diffusion Proteus mirabilis 5 mm Hameed et al., (2016)Pseudomonas eurogenosa 4 mmEscherichia coli 5.4 mmKlebsiella pneumonia 6 mmStaphylococcus aureus 5.2 mmCinnamomum verum bark/EOs Microdilution Acinetobacter spp. IC50 \u0001 625 \u03bcg/ml Guerra et al., (2012),Noudeh et al., (2010)Staphyllococcus aureus IC50 \u0001 0.2 mg/mlBacillus subtilis IC50 \u0001 0.4 mg/mlEscherichia coli IC50 \u0001 0.1 mg/mlPseudomonas eruginosa IC50 \u0001 0.2 mg/mlAgrobacterium tumefaciens IC50 \u0001 12.5 mg/mlDisk diffusion Staphylococcus aureus 17.2 mm Al-Bayati andMohammed, (2009)Bacillus cereus 18.3 mmEscherichia coli 15.7 mmProteus mirabilis 15.2 mmKlebsiella pneumonia 17.5 mmPseudomonas eruginosa 14.4 mmStaphylococcus aureus IC50 \u0001 62.5 \u03bcg/mlBacillus cereus IC50 \u0001 1.2 \u03bcg/mlEscherichia coli IC50 \u0001 62.5 \u03bcg/mlProteus mirabilis IC50 \u0001 125.0 \u03bcg/mlKlebsiella pneumonia MIC \u0001 62.5 \u03bcg/mlPseudomonas eruginosa MIC \u0001 125.0 \u03bcg/mlMembranepermeabilityreduction testEscherichia coli \u2193wall cell permeability Yap et al. (2015)Microdilution Pseudomonas putida IC50 \u0001 1 mg/ml Oussalah et al. (2006)(Continued on following page)Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 6001398Sharifi-Rad et al. Cinnamomum SpeciesTABLE 2 | (Continued) Preclinical pharmacological activities of Cinnamomum genus.PharmacologicalactivityCinnamum plant/extracts/fractionsMethods Models cellular lines(in vitro)/animal (in vivo)Effects/underlyingmechanismsRefAntidiabetic In vitro studiesCinnamomum verum bark/aqueous \u03b1-amylase, a-glucosidase inhibition IC50 \u0001 0.5, 1.25, 2.5 mg/ml Ranilla et al. (2010)\u2193\u03b1-amylase, \u2193\u03b1-glucosidaseCinnamomum verum bark/methanol Yeast a-glucosidase, rat-intestinala-glucosidase inhibitionIC50 \u0001 5.83 \u03bcg/ml Shihabudeen et al. (2011)\u2193yeast a-glucosidaseIC50 \u0001 670 \u03bcg/ml\u2193mammalian a-glucosidaseCinnamomum cassia (L.) J. Presl/Bark/acetone and aqueousGlucosidase, sucrase, maltase inhibition \u2193\u03b1-glucosidase inhibitoryactivity \u2191sucrase and maltaseinhibitionKang et al. (2014)Cinnamomum osmophloeum twig/aqueousPTP1B, a-glucosidase,\u03b1-amylase inhibition \u2193 a-amylase, \u2193\u03b1-glucosidase\u2193 PTP1BLin et al. (2016)In vivo studiesCinnamomum burmanni (nees and T.Nees) blume/bark/aqueousRats/very high fat diet inducedhyperglycemia 500, 300 mg/b.w.; oral\u2193FBG, dose dependentmannerCheng et al. (2012)Cinnamomum cassia (L.) J. Presl/bark/aqueousRats/glucose 2 g/kg b.w. ip; 85.7 mg/b.w oral \u2193blood glucose control:GlibenclamideVerspohl et al. (2005)Cinnamomum cassia (L.) J.Presl/aqueousMice/STZ induced diabetes; 100 mg/kg/day; oral \u2193blood glucose Chen et al. (2013)\u2191insulinCinnamomum cassia (L.) J.Presl/Bark/MethanolMice/STZ induced diabetes; 200 mg/b.w.; oral \u2193 blood glucose Kim et al. (2006)Cinnamomum cassia (L.) J. Presl bark/aqueousRats/alloxan induced diabetes 60 mg/b.w.; oral \u2193blood glucose Kamble andRambhimaiah, (2015)Cinnamomum porrectum bark/polyphenols rich extractRats/STZ induced diabetes 100,200,300 mg/b.w.;oral\u2193blood glucose Jia et al. (2009)Cinnamomum tamala/leaves/ethanol Rats/alloxan induced diabetes; 500 mg/b.w.; oral \u2193 blood glucose Kar et al. (2003)Cinnamomum tamala leaves/essential oilRats/STZ induced diabetes 10, 200 mg/b.w.; oral \u2193 blood glucose Kumar et al. (2012)Cinnamomum verum bark/water-soluble polyphenolsRats/STZ induced diabetes 200 mg/kg, oral \u2191weight loss \u2193FBG, \u2193PPG Krishnakumar et al. (2014)Cinnamomum verum bark/volatile oil Rats/STZ induced diabetes 20 mg/kg; oral \u2193plasma glucose Subash Babu et al. (2007)Cinnamomum verum essential oil Rats/STZ induced diabetes 20 mg/kg; oral \u2193blood glucose Al-LogmaniI and Zari,(2009)Cinnamomum verum stem bark/chloroformRats/STZ induced diabetes 20 mg/kg; oral \u2191muscle glycogen Anand et al. (2010)\u2191hepatic glycogen\u2193FBGCinnamomum verum bark/volatile oil Rats/alloxan induced diabetes 5, 10, 20 mg/kg; oral \u2193FBG, dose-dependentmannerMishra et al. (2010)\u2193cholesterol\u2193urinary protein\u2193TBARS\u2193blood urea\u2193catalaseCinnamomum verum bark/volatile oil Rats/alloxan induced diabetes \u2193FBG, dose-dependentmannerRajbir et al. (2009)5, 10 and 20 mg/kg; oralCinnamomumverum sticks/Aqueous Rats/STZ induced diabetes \u2193blood glucose, dose-dependent mannerShen et al. (2010)3, 30 and 100 mg/kg; oralCinnamomumverum bark/aqueous Rats/oral glucose tolerance test \u2193glycemic levels Kannappan et al. (2006)0.2 ml day/rat; oralCinnamomum verum/bark/methanol Rats/STZ induced diabetes \u2193 postprandialhyperglycemiaShihabudeen et al. (2011)300 mg/kg; oralAnti-inflammatory In vitro studiesCinnamomum cassia/cinnamicaldehydeRAW 264.7, LPS stimulated mice macrophages IC50\u0001 0, 6.25, 12.5, 25,50 \u03bcM anti-inflammatoryLiao et al. (2012a)Cinnamomum camphora/total crudeextract/80%methanol, hexane, ethyl acetatefractionsRAW 264.7, LPS stimulated mice macrophages IC50\u0001 100 \u03bcg/ml anti-inflammatoryLee et al. (2006)In vivo studiesCinnamomum cassia bark oil/cinnamaldehydeRats dose \u0001 2\u20136 mg/kg bw Chua et al. (2008)\u2193NF-kBCinnamomum cassia cinnamicaldehydeMice/carrageenan induced paw edema dose \u0001 1.25, 2.5,5 mg/kg/bwLiao et al. (2012a)Anti-inflammatory(Continued on following page)Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 6001399Sharifi-Rad et al. Cinnamomum SpeciesTABLE 2 | (Continued) Preclinical pharmacological activities of Cinnamomum genus.PharmacologicalactivityCinnamum plant/extracts/fractionsMethods Models cellular lines(in vitro)/animal (in vivo)Effects/underlyingmechanismsRefAnti-cancer In vitro studiesC. burmanni stem bark/methanolic NPC/HK1, C666\u20131, human cancer cell lines \u2191cytotoxicity Daker et al. (2013)IC50 \u0001 224.3 \u03bcg/mlIC50 \u0001 6.30 \u03bcg/mlC. cassia bark aqueous SiHa, human cervical carcinoma cell lines \u2193growth of cancer cells Koppikar et al. (2010)\u2191cytotoxicityIC50 \u0001 80 \u03bcg/mlC. cassia ethanolic extract HT 29, HCT 116, human colorectalcarcinoma cell lines\u2191Nrf2 Wondrak et al. (2010)\u2191antioxidantC. burmann stem bark/aqueous Lymphoma, melanoma, mice cancer cell lines \u2193tumor cell growth Kwon et al. (2010)\u2191cytotoxicityIC50 \u0001 0.5 mg/mlCinnamomum speciescinnamaldehydeHep G2, hepatoma cells line \u2191apoptosis Ng and Wu. (2011)\u2191p53, \u2191APO-1\u2191cytotoxicityIC50 \u0001 9.8 \u03bcMC. subavenium miq subamolide Dsubamolide ESW 480, human colon adenocarcinoma cell linesA431, SCC1 human epidermoid carcinomacells A375, human melanoma cell lines\u2191DNA damage Kuo et al. (2008); Yanget al. (2013)\u2191cytotoxicityIC50 \u0001 9.12 \u03bcg/mlIC50 \u0001 13.30 \u03bcg/mlIC50 \u0001 17.59 \u03bcg/mlC. subavenium miq subamolide B, A NTUB1, human urothelial carcinoma cell line SW480,human colon adenocarcinoma cell line\u2193tyrosinase Chen et al. (2007); Wanget al. (2011)\u2191apoptosisC. tenuifolium/butanolides DU145, human prostate cancer cell line \u2193mitochondrialtransmembrane potentialLin et al. (2009)\u2191cytochrome C\u2191caspase-9/caspase-3\u2191cytotoxicityNeuroprotective In vitro studiesCinnamomum species water extract/procyanidin type a trimerC6 glial cells, OGD exposed \u2193glial cell swelling Panickar et al. (2012)\u2193glutamate uptakeCinnamomum cassia/extract/cinnamaldehydeBV2 microglias, LPS activated \u2193neuroinflammation Ho et al. (2013)IC50 \u0001 50 \u03bcg/mlIn vivo studiesCinnamomum species trans-cinnamaldehydeMice/6-OHDA treated intracerebroventricular Anti-neuroinflammatory Pyo et al. (2013)Dose \u0001 30 mg/kgCinnamomum zeylanicum bark extract Rats/SCOP treated intravenous \u2191cognition dose \u0001 100, 200,400 mg/kgJain et al. (2015)OtherspharmacologicalactivitiesIn vivo studiesCinnamomum zeylanicum/stem bark/methanol extractRats/L-name-induced hypertension, intravenous Antihypertensive Nyadjeu et al. (2011)dose \u0001 5, 10, 20 mg/kgCinnamomum zeylanicum/bark andleaf/EOsCulex quinquefasciatus, Anopheles tessellatus andAedes egyptiMosquitocidal Samarasekera et al.(2005)Bark oilA. essellatusLD50 \u0001 0.33 \u03bcg/mlC. uinquefasciatusLD50 \u0001 0.66 \u03bcg/ml leaf oilLD50 \u0001 1.03\u20132.1 \u03bcg/mlCinnamomum zeylanicum bark/EOs Pediculushumanus capitis Ovicidal, adulticidal activities Yang et al. (2005)LD50 \u0001 0.5 mg/cm2Cinnamomum zeylanicum bark/aqueous suspensionRats Anti-secretagogue Alqasoumi. (2012)Antiulcerdose \u0001 250, 500 mg/kg b.wCinnamomum zeylanicum bark/ethanol extractRats Pro-healing effect Kamath et al. (2003);Farahpour and Habibi.(2012)dose \u0001 250, 500 mg/kg b.wCinnamomum zeylanicum bark/ethanol extractRats/CCl4-induced liver injury \u2191hepatoprotective Eidi et al. (2012)Dose \u0001 0.01, 0.05, 0.1 g/kgAbbreviations and symbols: \u2191, increase; \u2193, decrease; APOA-1, Apolipoprotein A-1; bw, body weight; FBG, fasting blood glucose; L-NAME, N(G)-nitro-L-arginine-methyl ester, LPS,lipopolysaccharide; p53, tumorprotein p53; PPG, postprandial plasma glucose; PTP1B, protein-tyrosine phosphatase; NF-\u03baB, nuclear factor \u03baB; OGD, oxygen-glucose deprivation; 6-OHDA, 6-hydroxydopamine; SCOP, scopolamine; STZ, streptozotocin; TBARS, thiobarbituric acid reactive substances.Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013910Sharifi-Rad et al. Cinnamomum SpeciesThe antidiabetic mechanisms of natural compounds derivedfrom Cinnamomum spp. are explained as follow: 1) stimulation ofinsulin secretion by pancreatic \u03b2-cells of the islets of Langerhans,2) increasing the muscle and hepatic glycogen content, 3)inhibition of \u03b1-amylase and \u03b1-glucosidase activities (keyenzymes of carbohydrate metabolism) (Subash Babu et al.,2007; Zhang et al., 2008) 4) stimulation of glycogen synthesisand cellular glucose uptake by membrane translocation of glucosetransporter (GLUT 4); stimulation of the glucose metabolism, 5)reduction of the gluconeogenesis by its actions on the mostimportant regulatory enzymes, 6) potentiation of insulinrelease and increasing insulin receptor activity (Bandara et al.,2012; Ranasinghe et al., 2012). (Figure 3) and Table 2.The antihyperglycemic action of the soluble polyphenols of C.verum bark was verified in SZT-induced diabetic rats at the doseof 200 mg/body weight (Krishnakumar et al., 2014).Cinnamaldehyde isolated from the volatile oil of C. verumshowed a highly significant effect on plasma glucose levelsusing a rat model of SZT-induced diabetes (Subash Babuet al., 2007). This major component has a wide variety ofpharmacological properties, including antihyperglycaemicactivity in diabetic rats (Subash Babu et al., 2007; Zhang et al.,2008). Al-LogmaniI and Zari (2009) have also tested the EO of C.verum and showed an important reduction in blood sugar levels.The chloroform extract of C. verum bark stem exhibitedantidiabetic activity in vivo at 20 mg/body weight using a ratmodel of SZT-induced diabetes (Anand et al., 2010). Theauthors demonstrated that the chemical compounds ofextract increased the muscle and liver glycogen content. Byusing alloxan-induced diabetes in rats, other studies showed thatthe EO of C. verum bark decreased fasting blood sugar in a dose-dependent manner and reduced total cholesterol level, bloodurea, urinary protein, thiobarbituric acid reactive substances(TBARS), and catalase levels in diabetic rats (Rajbir et al., 2009;Mishra et al., 2010). A few studies have reported the antidiabeticeffect of C. verum aqueous extracts (Verspohl et al., 2005;Kannappan et al., 2006; Ranilla et al., 2010; Shen et al., 2010;Chen et al., 2013).The antihyperglycemic activity can also be evaluated by theinhibition test of \u03b1-glucosidase and \u03b1-amylase. Inhibitors of theseenzymes are intended to maintain glucose homeostasis indiabetics by decreasing the rate of glucose uptake (B\u00f6senbergand van Zyl, 2008; Hanhineva et al., 2010). (Ranilla et al., 2010)showed an important inhibition of \u03b1-glucosidase and \u03b1-amylaseactions by C. verum bark aqueous extract. The same extractattenuated hyperglycemia depending on the dose in SZT diabeticrats (Shen et al., 2010; Chen et al., 2013). The antidiabetic effect ofthis extract was confirmed by the decrease in blood glucose usingoral glucose tolerance test in rats (Kannappan et al., 2006; Chenet al., 2013).In an in vitro study, C. verum showed a potential antidiabeticeffect by reducing post-prandial intestinal glucose absorption viaenzymatic reduction of pancreatic \u03b1\u2013amylase and intestinal\u03b1\u2013glucosidase. In vivo studies also confirmed the anti-hyperglycemic effects of C. verum (Bandara et al., 2012;Ranasinghe et al., 2012) through the decrease in LDLcholesterol, total cholesterol and triglycerides with increasingHDL in hyper-lipidaemic albino rabbits. (Javed et al., 2012).FIGURE 3 | Potential mechanisms of antidiabetic effects of chemical compounds of Cinnamomum plants. Body cells mean all the human cells with receptors forinsulin.Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013911Sharifi-Rad et al. Cinnamomum SpeciesAntioxidant ActivitySome clinical investigations showed that long term consumptionof cinnamon extracts improved the levels of blood markers ofoxidative stress, such as the antioxidant capacity. The extractsalso reduced the transaminase and lipid peroxidase activities(Ranjbar et al., 2007; Rashidi et al., 2014). Diverse tests wereused to evaluate potential antioxidant action of Cinnamomumplant extracts and secondary metabolites. These include 2,2\u2032-azinobis (3-ethyl-benzothiazoline-6-sulphonic acid (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), ferric reducing antioxidantpower (FRAP), oxygen radical absorbance capacity (ORAC),Folin Ciocalteau reduction assay (FCR), \u03b2 carotene linoleicacid bleaching (BCLB), and enzyme inhibition assays.The antioxidant activity of C. osmophloeum leaf EOs wasassessed using DPPH radical scavenging assay, with IC50 \u000129.7 \u03bcg/ml (Lin et al., 2007). The ethanol extract of the samespecies was tested using DPPH and FRAP assays by (Lee et al.,2015). The results showed inhibitory values of 38.97 and 0.48% byDPPH and FRAP test, respectively.(Prasad et al., 2009) tested the antioxidant activity of ethanolicextract of Cinnamomum curvifolium (Lam.) Nees, C. burmanni,C. cassia, C. verum, and C. tamala using DPPH, FRAP and ORACassays. All tested species showed important antioxidant activitieswith some variability depending on the species and the usedmethod (Prasad et al., 2009). C. cassia was also reported as anantioxidant species by several studies (Lin et al., 2003; Kim et al.,2006; Jang et al., 2007). C. cassia water extract showed importantcapacities to inhibit the key enzymes involved in ROS generationsuch as catalase, superoxide dismutase and glutathioneperoxidase (Kim et al., 2006). Methanolic extract of C. verumrevealed remarkable antioxidant activities particularly bychelating metal and inhibition of lipid peroxidation (Mathewand Abraham, 2006). Moreover, the inhibition of lipidperoxidation was also demonstrated by EOs of C. verum(Jayaprakasha et al., 2003; Jayaprakasha et al., 2006). Theresearch that highlighted the antioxidative activity ofCinnamomum plants is summarized in Table 2.Anti-inflammatory ActivitiesInflammation is an important pathophysiological process of theorganism that maintains homeostasis, fighting pathogens andrepairing damaged tissues caused by various injuries such astrauma, infection or immune response (Salehi et al., 2019b),(Stalnikowitz and Weissbrod, 2003). The same inflammatoryprocess is involved in the maintenance of several disordersand is characterized by the production of diverse pro-inflammatory mediators (Salehi et al., 2020a). The currentcommon class of medications against inflammation disordersstill relies on non-steroidal anti-inflammatory drugs (Padureanuet al., 2019). However, in spite of having important anti-inflammatory potential, these drug class can cause several sideeffects such as bleeding, kidney failure and gastrointestinalulceration. Therefore, increasing attention has been directedtowards natural and health-friendly alternatives (Salehi et al.,2019c; Salehi et al., 2019d). The use of natural compoundsconstitutes an attractive approach for the treatment of severalinflammatory disorders.Inflammation involves reactive oxygen species (ROS)generation, NO production, phospholipase A2 activation andhistamine release in neutrophils, macrophages and mast cells.NO has an important role in lipopolysaccharide (LPS), TNF orIL-1 mediated inflammatory process. It is also essential in the cellfunctionmaintenance (Stalnikowitz andWeissbrod, 2003) though,on the other hand, NO is able to induce cell injury as a reactiveradical. The activator protein-1 (AP-1) and nuclear factor kappa B(NF-kB) are important modulators of inflammation.The main mechanism of the anti-inflammatory activity of themajor chemical compound of Cinnamomum plants,cinnamaldehyde is the effective inhibitor of the expression ofNF-kB mediated by its antioxidant activity (Kim et al., 2007). Inaddition, cinnamaldehyde inhibits pro-inflammatory mediatorssuch as chemokines, interferons, interleukins, lymphokines,eicosanoids (prostaglandins and leukotrienes) and ROSinvolved in Alzheimer\u2019s disease (Latta et al., 2015). PreclinicalFIGURE 4 | Summarized mechanisms of neuroprotective effects ofCinnamomum plants. Abbreviations: SIRT1, Sirtuin 1; MAPK, mitogen-activated protein kinase; iNOS, inducible Nitric Oxide synthase; TNF-\u03b3, tumornecrosis factor; COX-2, Cyclooxygenase-2; NF-kB, Nuclear Factor-Kappa B; p65 (RelA subunit of NF-\u03baB family of transcription factors); Bcl-2,B-cell lymphoma 2; IL-1b, Interleukin-1beta; IL-6, Interleukin 6.Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013912Sharifi-Rad et al. Cinnamomum Speciesstudies showed a reasonably good anti-inflammatory effect ofCinnamomum constituents. Diverse extracts and isolatedcompounds of Cinnamomum plants have been studied forpossible anti-inflammatory activity in various animal models.(Liao et al., 2012b) showed an anti-inflammatory effect ofcinnamaldehyde on lipopolysaccharide (LPS) stimulated mousemacrophage (RAW 264.7) at 50 \u00b5M.The in vivo investigations confirmed the anti-inflammatoryeffect using the carrageenan-induced mouse paw edema (Liaoet al., 2012b). Cinnamic alcohol (another volatile compound fromCinnamomum plants) also exerted anti-inflammatory activityusing the same model (Liao et al., 2012b). In another study,cinnamyl acetate revealed a significant anti-inflammatory actionon LPS-stimulated mouse macrophages (RAW264.7) (Chua et al.,2008). The research highlighting the anti-inflammatory activityof Cinnamomum plants is displayed in Table 2.Anticancer ActivitiesRecent researches showed that the in vivo anticancer activity ofthe cinnamon extract was mediated by the induction of tumorapoptosis through the inhibition of NF-\u03baB levels (Kwon et al.,2010). On the other hand, cinnamon showed important anti-cancer effects via affecting on numerous cancer-related pathwayssuch as apoptosis (Kwon et al., 2010). This apoptotic action ismediated by targeting Fas/Fas/CD95, caspase-3, and Bcl-XL(B-cell lymphoma-extra-large) pathways (Sadeghi et al., 2019).C. burmanni stem bark methanolic extract was tested onhuman cell lines (NPC/HK1 and C666-1) by Daker et al.(2013). The results showed important cytotoxic effect againstHK1 (IC50 \u0001 224.3 \u03bcg/ml) and C666-1 (IC50 \u0001 6.30 \u03bcg/ml)Daker et al. (2013). Koppikar et al. (2010) tested the aqueousbark extract of C. cassia on human cervical carcinoma (SiHa) celllines. This extract decreased the growth of cancer up to 2-foldcompared to the untreated control cells at the concentration of80 \u03bcg/ml Koppikar et al. (2010).In another study, the ethanolic extract of the same speciestested by Wondrak et al. (2010) on human colorectal carcinoma(HCT 116 and HT 29) cell lines showed anticancer properties.The C. cassia bark aqueous extract was evaluated on cancer celllines of lymphoma, melanoma and cervix as well as in amelanoma mouse model (Kwon et al., 2010). The cinnamonextract inhibited tumor cell growth in vitro at 0.5 mg/ml.Cinnamaldehyde showed an important antitumor effect as well(Ng and Wu, 2011). It inhibited the growth of hepatoma Hep G2cells line at IC50 \u0001 9.8 \u03bcM. Some bioactive compounds isolatedfrom Cinnamomum subaveniumMiq. such as subamolide D and Eshowed remarkable anticancer effects on human colonadenocarcinoma (SW 480) cell lines. The cytotoxic effect wasmediated by the capacity of these compounds to cause DNAdamage in a dose- and time-dependent manner (Kuo et al.,2008). Moreover, subamolide B isolated from the stem of thesame plant showed significant cytotoxic effects on humanSCC12 (IC50 \u0001 9.12 \u03bcg/ml), epidermoid carcinoma A431 (IC50 \u000113.30 \u03bcg/ml), and human melanoma A375 (IC50 \u0001 17.59 \u03bcg/ml)cell lines (Yang et al., 2013).In another study, subamolide B and its isomer subamolide Ainduced apoptosis in human colon adenocarcinoma cell lineSW480 and human urothelial carcinoma cell lineNTUB1(Chen et al., 2007; Wang et al., 2011). Furthermore,subamolide E, isolated from C. subavenium, exhibited animportant in vitro anti-melanoma activity (Kuo et al., 2008;Wang et al., 2011). (Lin et al., 2009) reported that butanolidesisolated from the stem of Cinnamomum tenuifolium (Makino)Sugim showed anticancer activity on human prostate cancer(DU145) cell line. (Lin et al., 2009). In addition, the extractsof C. kotoense was found cytotoxic against HeLa cells (Chen et al.,2008). Butanolides isolated from the C. kotoense leaves reportedgenotoxic and cytotoxic effects on various cell lines, such ashuman laryngeal carcinoma cells Hep-2, Chinese hamsterovarian cells CHO-K1 and rat hepatoma tissue cultures(Garcez et al., 2005) and mouse lymphoid leukemia P-388cells (Tsai et al., 2002). In vitro antineoplastic activities ofCinnamomum species are summarized in Table 2.Neuroprotective Activities: PotentialMechanisms and Molecular Targets inNeurodegenerative DiseasesParkinson\u2019s and Alzheimer\u2019s diseases are commonneurodegenerative diseases, accompanied by cognitive andmemory impairments, sometimes difficult to differentiate fromreal psychosis or other neurological diseases (Nussbaum et al.,2017; Buga et al., 2019; Tsatsakis et al., 2019). The mechanisms ofneuroprotective effects of Cinnamomum plants and theirderivatives have been reported by several studies (Liao et al.,2008; Peng et al., 2008; Peterson et al., 2009; Panickar et al., 2012;Jiao et al., 2013). (Figure 4).(Ho et al., 2013) showed that procyanidinA trimer 1 (a bioactivecompound isolated from C. burmanni) had an essentialneuroprotective effect which reduced the glial swelling byregulating the intracellular calcium concentration in glialneuronal cells (Peng et al., 2008). Procyanidin exhibitedneuroprotective activity by its capacity to regulate the secretionof S100 via the regulation of SIRT1 and the suppression of TNF-\u03b3,NF-kB p65 (RelA subunit of NF-\u03baB family of transcription factors)and B-cell lymphoma 2 (Bcl-2) on glioma cells (Jiao et al., 2013).(Panickar et al., 2012) studied the neuroprotection ofprocyanidin B2 isolated from C. verum. The results showed thatthis molecule inhibited advanced glycation end-product productionin the bovine serum albumin-glucose model (Panickar et al., 2012).Cinnamaldehyde is a volatile compound found in C. cassiaextracts. (Ho et al., 2013) showed that this compound possessedan important neuroprotective effect by reducing the expression ofNO, tumor necrosis factor (NF-\u03b3), interleukin-1beta (IL-1b),interleukin 6 (IL-6), and nuclear factor-kappa B (NF-kB) inLPS induced BV2 microglia cells.In a recent study, (Liao et al., 2008) revealed thatcinnamaldehyde from C. cassia exhibited remarkableneuroprotection by the reduction of TNF\u03b3-induced expressionof cell adhesion molecules, the suppression of nuclear factor-kappa B (NF-kB) and the reduction of intracellular thiols inendothelial cells (Liao et al., 2008).Cinnamaldehyde isolated from C. ramulus exhibited anti-neuro-inflammatory properties by the inhibition of inducibleFrontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013913Sharifi-Rad et al. Cinnamomum SpeciesTABLE 3 | Description of recent clinical studies related to pharmacological activity of natural compounds from Cinnamomum species.PharmacologicalactivityClinical trial/studydesign (type,patients included)Period, country Intervention (dosesof Cinnamonand itsderivatives)StandardcomparisonThe mostrepresentativeclinicaloutcomesRefType 2 diabetes Two groups included:Cinnamon- group 1,2, 3Department ofHuman Nutrition,NWFP AgriculturalUniversity, Peshawar,PakistanCinnamon group: 500 mgcapsule of Cinnamomumcassia placebo group:Wheat flour, 500 mg, 1 g or2 capsules per day for 20days; group 1 and 4: 3 g or 6capsules per day for20 days; group 2 and 5: 6 gor 12 capsules per day for20 days; group 3 and 6; 6 gor 12 capsules per day for40 daysPlacebo \u2193serum glucose(18\u201329%), \u2193TG(23\u201330%), \u2193LDL-C(7\u201327%) \u2193totalcholesterol (12\u201326%)Khan et al. (2003)Placebo- group 4, 5, 6Cinnamon group: 60patientsAge 52.2 \u00b1 6.32 yearsNot on insulin therapyNot taking othermedicineFasting blood glucoseLevels 7.8\u201322.2 mmol/LType 2 diabetes Cinnamon group: 33patients, age 62\u00b78 \u00b1 8\u00b737Hannover, Germany Cinnamon group: Extract112 mg aqueous cinnamonextract placebo:Microcrystalline cellulose 3 gpowder per day, three timesa day for 4 monthsPlacebo \u2193glucose levels upto 10.3%Mang et al. (2006)Body weight 88\u00b75 \u00b119\u00b71 kgHbA1c 6.7\u20136.9%Placebo group: 32patients age 63\u00b77 \u00b17\u00b717 yearsBody weight 89\u00b79 \u00b114\u00b71 kgHbA1c 6.7\u20136.9%Type 2 diabetes Cinnamon group Netherlands Cinnamon group: 500 mg ofCinnamomum cassiaplacebo group: 500 mg,wheat flour, verstegen 1.5 gper day, 1 capsule atbreakfast, lunch and dinnerfor 6 weeksPlacebo \u2193plasma glucose,\u2193plasma insulin, \u2193totalcholesterol, \u2193LDL, \u2193TG\u2193HDL \u2193HbA1cVanschoonbeeket al. (2006)12 postmenopausalwomen age 62 \u00b1 2 yearsBody weight 85.4 \u00b13.6 kgPlacebo group: 13patientsAge 64 \u00b1 2 yearsBody weight 82.2 \u00b14.0 kgType 2 diabetes Cinnamon group: 30patientsUS Cinnamon group: 500 mgcapsule of Cinnamomumcassia placebo group:Wheat flour, 500 mgcapsule: 1 g per day, forbreakfast and dinner for3 monthsPlacebo No significant change inFBG, lipid for cinnamongroupBlevins et al. (2007)Age 63.6 yearsPlacebo: 22 patientsAge 58.0 yearsType 2 diabetes Cinnamon group: 55patientsUnited States militarybase, May 2007 toAugust 2007Cinnamon group: Capsules500 mg capsule ofCinnamomum cassia controlgroup: 1 g/day with food for90 daysControl Cinnamon group \u2193HbA1cCrawford. (2009)Age 60.5 \u00b1 10.7HbA1c \u2265 7.0% controlgroup: 54 patientsAge 59.9 \u00b1 9.2 yearsHbA1c \u2265 7.0%Multi-ethnic type 2diabeticCinnamon group: 58patients, age 54.9 \u00b19.8 yearsOctober 2007 toJanuary 2009,United KingdomCinnamon group: 500 mgcapsule of Cinnamomumcassia placebo: Starch,500 mg capsule 2 g per day,for breakfast (1 capsule),lunch (2 capsules), dinner (1capsule) for 12 weeksPlacebo \u2193HbA1c \u2193FPG \u2193BMI Akilen et al. (2010)Body weight 74.94 \u00b113.34; FPG\u2265 7 mmol/LHbA1c \u2265 7.0% placebogroup: 22 patientsAge 55.67 \u00b1 7.98 yearsBody weight 73.02 \u00b110.38 yearsFPG\u22657 mmol\u2044 lHbA1c \u2265 7.0%(Continued on following page)Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013914Sharifi-Rad et al. Cinnamomum SpeciesTABLE 3 | (Continued) Description of recent clinical studies related to pharmacological activity of natural compounds from Cinnamomum species.PharmacologicalactivityClinical trial/studydesign (type,patients included)Period, country Intervention (dosesof Cinnamonand itsderivatives)StandardcomparisonThe mostrepresentativeclinicaloutcomesRefType 2 diabetes Cinnamon group: 22patientsTehran, Iran Cinnamon group: 500 mgcapsule of Cinnamomumzeylanicum placebo group:500 mg capsule, wheat flour3 g per day, 2 capsules atbreakfast, lunch and dinnerfor 8 weeksPlacebo No significant differencein cinnamon andplacebo group onHbA1c, \u2193TG, \u2193Insulin \u2191LDL-CVafa et al. (2012)Age 54.11 \u00b1 10.37 yearsBody weight 74.94 \u00b113.34Placebo group: 22patientsAge 55.67 \u00b1 7.98 yearsBody weight 73.02 \u00b110.38 kgType 2 diabetes Cinnamon group: 137patientsBeijing and dalian,ChinaCinnamon group: Waterextract of cinnamon andCinSulin\u00ae, 250 mg/capsuleplacebo: 500 mg capsule,wheat flour daily, twice a dayfor 2 monthsPlacebo \u2193LDL-C \u2193HDL\u2193HOMA-IRAnderson et al.(2015)Age 61.3 \u00b1 0.8 yearsType 2 diabetes Cross-over studycinnamon group:10sedentary obesefemalesTexas, United States Cinnamon group: 1\u20136 g/daypowder of C. cassia/aromaticum andC. zeylanicum/verumplacebo: Cellulosepowder 5 gPlacebo No differences observedin blood glucose, seruminsulin, insulin sensitivity,insulin resistanceGutierrez et al.(2016)Age 22.7 \u00b1 4 yearsBody weight 104.42 \u00b116.75 kgTake oral/intrauterinecontraceptivesPrescriptionmedicationsOver-the-counter weightloss pillsType 2 diabetes Cinnamon group: 40patientsSeptember 2012 toDecember 2012, IranCinnamon group:Cinnamomum verum 3 g for8 weeks control group: 3glasses of tea, for 8 weeksControl \u2193sICAM-1 Azimi et al. (2016)Age 54.15 \u00b1 1.0 yearsWeight 75.62 \u00b1 1.2 kgControl group:40patientsAge 53.64 \u00b1 1.3 yearsWeight 78.74 \u00b1 1.2 kgPolycystic ovarysyndromeHerbal medicine pluslifestyle interventionstudyAugust 2012 toJanuary 2014,AustraliaGlycyrrhiza glabra, Paeonialactiflora, Cinnamomumverum, Hypericumperforatum: three tablet perday for 3 monthsLifestyleintervention\u2193 oligomenorrhoea \u2193BMI \u2193 weightArentz et al. (2017)Cinnamon group: 60overweight womenAge 29.2 \u00b1 5.6 yearsWeight 93.2 \u00b1 18.9 kgLifestyle interventiongroup: 62 patients age28.9 \u00b1 5.6Weight 97.3 \u00b1 21.3 kgPolycystic ovarysyndromeCinnamon group: 29patientsIran Cinnamon group: 500 mgcapsules (450 mg capsule ofstarch and 50 mg cinnamonpowder): 1.5 g per day threetimes, after a meal with10 mgmedroxyprogesterone tabletfrom 15th day ofmenstruation cycle for10 days for 12 weeksPlacebo \u2193fasting insulin,\u2193HOMA-IR, \u2193LDL, \u2193TG,\u2193testosterone, \u2193 insulin,\u2193 weight \u2193HbA1cHajimonfarednejadet al. (2018a)Age 18\u201345 yearsWeight 68.24 \u00b1 9.68 kgPlacebo group: 30patientsAge 18\u201345 years63.26 \u00b1 11.62 kg(Continued on following page)Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013915Sharifi-Rad et al. Cinnamomum Speciesnitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) inLPS-induced BV2 microglial cells (Pyo et al., 2013).In addition, cinnamon bioactive compounds exhibitedneuroprotective effects in in vivo models of Alzheimer\u2019sdisease and extended the lifespan via regulation of keyantioxidant pathways (Crews et al., 2016). C. verum extractsprovided an important protection against Alzheimer\u2019s diseaseand dementia in the scopolamine-induced memory impairmentin experimental rat model (Jain et al., 2015).In the same way, a different mixture of cinnamon rich inpolyphenols exhibited important neuroprotective activities in ratglioma cells by suppression of pro-inflammatory cytokines,upregulation of sirtuin 1 (SIRT1) and activation of mitogen-activated protein kinase (MAPK) pathways (Qin et al., 2014).Neuroprotective activities of Cinnamomum plants are tabulatedin Table 2.Other Pharmacological ActivitiesCinnamomum plants have also shown an array of other biologicalactivities. (Nyadjeu et al., 2011) reported that C. verum extractsdecreased arterial blood pressure in rats with normal arterialhypertension and various models of hypertensive rats (salt-loaded and spontaneously) (Nyadjeu et al., 2011). In anotherstudy, (Wansi et al., 2007) reported that C. verum extracts showedsimilar effects in arterial blood pressure of normotensive rats andsalt-loaded hypertensive rats. Moreover, they showed that C.verum had a vasorelaxant action on the thoracic aortic ringsegments, which suggests that C. verum might inhibitTABLE 3 | (Continued) Description of recent clinical studies related to pharmacological activity of natural compounds from Cinnamomum species.PharmacologicalactivityClinical trial/studydesign (type,patients included)Period, country Intervention (dosesof Cinnamonand itsderivatives)StandardcomparisonThe mostrepresentativeclinicaloutcomesRefPolycystic ovarysyndromeCinnamon group: 42patients with rotterdamcriteriaseptember 2015 tojanuray 2016, tehran,IranCinnamon group: 500 mgcapsule/day placebo: Wheatflour: 1.5 g per day for8 weeksPlacebo \u2191antioxidant capacity\u2193malondialdehyde\u2193 BMIBorzoei et al.(2018a)Age 29.26 yearsPlacebo group: 42patients with rotterdamcriteriaAge 30 yearsPolycystic ovarysyndromeCinnamon group: 42patients with rotterdamcriteriaMohheb YasHospital, Tehran,Iran, October 2015 toFebruary 2016Cinnamon group: 500 mgcapsule/day placebo: Wheatflour: 1.5 g per day for8 weeksPlacebo \u2193TG, \u2193BMI, \u2193TC\u2193HOMA-IR \u2193insulin, \u2193LDL-C HDL-CunchangedBorzoei et al.(2018b)Age 29.3 yearsWeight 76.6 kgPlacebo group: 42patients with rotterdamcriteriaAge 30.2 yearsWeight 77.7 kgPolycystic ovariansyndromeCinnamon group March 2011 to April2014 toUnited StatesCinnamon (125 mg capsule)or placebo: 1.5 gm per dayfor 6 monthsPlacebo \u2191 homa-ir Kort and Lobo.(2014a)11 patients, age18\u201338 years witholigomenorrhea oramenorrheaPlacebo group: 6patientsAge 18\u201338 yearsPolycystic ovariansyndromeDLBS3233: 18 patients March 2013 andJune 2015 at yasminclinic, RSCMkencana, jakarta andhasan sadikinhospital, bandungDLBS3233 (Cinnamomumburmanii and Lagerstroemiaspeciosa): 200 mg per dayfor 6 months metformingroup: 1.5 g per day for6 monthsControl \u2193AMH level Wiweko andSusanto. (2017)Metformin group: 22patientsPolycystic ovariansyndromePatients age 23.29 \u00b15.10 with rotterdam,overweight or obeseSaudi Arabia Cinnamon extract(336 mg/day)Placebo \u2193BMI Talaat and Ammar,(2018)Polycystic ovarysyndrome40 patients age18\u201330 years2017, ahvaz, Iran 6 weeks Interventiongroup\u2193weight glucosehomeostasis no effectsParseh et al. (2019)Polycystic ovarysyndromeCinnamon group: 20patients, age18\u201342 years withrotterdam criteriaDecember 2014 toMarch 2016, nationalinstitute of unanimedicine (NIUM)hospital, BengaluruCinnamon group: 750 mgcapsule,1.5 g/day controlgroup: 500 mg metformintwice a day for 60 daysControl Menstrual cycleinprovment increased51.9%, insulinresistance unchangedKhan and Begum.(2019)Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013916Sharifi-Rad et al. Cinnamomum Speciesextracellular calcium through L-type voltage-sensitive channels(Wansi et al., 2007).The antiparasitic effects of EOs from bark and leaves of C.verum were investigated by (Samarasekera et al., 2005) againstAnopheles tessellates, Culex quinquefasciatus, and Aedes aegypti.These oils showed knock-down and mortality against A.tessellatus (LD50 \u0001 0.33 \u03bcg/ml) and C. quinquefasciatus (LD50\u0001 0.66 \u03bcg/ml). (Yang et al., 2005) showed fewer effect of C. verumbark EO against Pediculus humanus capitis (eggs, adult females ofhuman head louse) than either phenothrin or pyrethrum usingdirect contact bioassay (Yang et al., 2005).Collagen synthesis was stimulated in human dermalfibroblasts by C. verum extracts (Takasao et al., 2012). C.verum extract enhanced both mRNA and protein expressionlevels of type I collagen without cytotoxicity, andcinnamaldehyde was the most active component stimulatingthe expression of collagen, suggesting that C. verum extractsmight be useful in skin anti-aging treatments (Takasao et al.,2012). Moreover, C. verum extracts inhibited osteoclastogenesis(Tsuji-Naito, 2008). At concentrations of 12.5\u201350 \u03bcg/ml, C.verum inhibited osteoclast-like cell formation in a dose-dependent manner without affecting cell viability. This findingsuggests its potential use in the treatment of osteopenia diseases(Tsuji-Naito, 2008). In addition, C. verum exhibited in vivo anti-secretagogue and anti-gastric ulcer effects (Alqasoumi, 2012). Inpylorus-ligated rats, C. verum extract pre-treatment reduced thebasal gastric acid secretion and inhibited gastric hemorrhagiclesions (Alqasoumi, 2012). Furthermore, C. verum extracts at 100and 200 mg/b. w. effectively diminished the extent of diarrhea(71.7 and 80.4%, respectively) in test animals (RAO, 2012).In another research performed in two rat models, theevaluation of anti-nociceptive effects of C. verum and selectedplants showed that C. verum produced a dose-dependentanalgesic protective effect against thermal stimuli. Moreover,C. verum enhanced an anti-inflammatory activity againstchronic inflammation of cotton pellet granuloma (Atta andAlkofahi, 1998; RAO, 2012). C. verumhas also demonstratedwound healing properties (Kamath et al., 2003; Farahpour andHabibi, 2012). C. verum (0.01, 0.05, and 0.1 g/b. w. for 28 days)displayed hepatoprotective effects in a study where the liverinjury was induced in rats by CCl4 (carbon tetrachloride) (Eidiet al., 2012). Other pharmacological properties of Cinnamomumplants are summarized in Table 2.CLINICAL TRIALS RELATED TO EFFICACYOF BIOACTIVE COMPOUNDS DERIVEDFROM CINNAMOMUMType 2 Diabetes Mellitus, Obesity andMetabolic SyndromeCinnamon consumption was associated with reduction in thelevels of fasting plasma glucose (FPG), total cholesterol (TC),triglyceride levels (TG), LDL cholesterol and hemoglobin A1c(HbA1c). In one study, cinnamon consumption resulted insignificantly increased FPG levels and HbA1c (Blevins et al.,2007) or no significant change in HDL cholesterol levels.However, the most preferred and effective doses with fewerside effects are still not clear. Doses applied in randomizedclinical trials showed conflicting results as consumption of 1 g/day (Khan et al., 2003; Blevins et al., 2007; Crawford, 2009), 1.5 g/day (Vanschoonbeek et al., 2006; Radhia et al., 2010), 2 g/day(Akilen et al., 2010), 3 g/day (Khan et al., 2003; Mang et al., 2006;Vafa et al., 2012), or 5 g/day (Gutierrez et al., 2016), 6 g/day(Khan et al., 2003) showed different effects in glycemic and lipidparameters. FPG and HbA1c are commonly used parameters fordiabetes diagnosis. HbA1c values of more than 6.5% can berelated to diabetes. Vafa et al. showed FPG and HbA1c atbaseline modestly elevated (7.02 mmol/L to 8 mmol/L) and6.9\u20138.0%, respectively (Vafa et al., 2012). Both the studies byAkilen et al. and Crowfrod reported a drop of 0.36 and 0.83% ofHbA1c values at low dose cinnamon supplementation whichwere safe and well tolerated for 3 months in patients usingsimultaneous hypoglycemic medications (Crawford, 2009;Akilen et al., 2010). Mang et al. observed that aqueous extractof cassia cinnamon significantly reduced glucose levels like 10.3%in the cinnamon group and 3.4% in the placebo group, however,no considerable difference in HbA1c and cholesterol (LDL, HDL,TC) levels were observed (Mang et al., 2006). Suppapitiporn et al.observed no significant differences in cinnamon and placebogroup for FPG and lipid profiles but HbA1c level decreased inboth groups by 0.38 and 0.19% respectively (Suppapitiporn andKanpaksi, 2006).Khan et al. reported that intake of 1, 3, or 6 g of cinnamonreduced fasting serum glucose by 18\u201329%, LDL by 7\u201327%,triacylglycerol by 23\u201330%, and total cholesterol by 12 26%after 40 days treatment. Nevertheless, they did not investigatethe HbA1c value (Khan et al., 2003). One study showed that,consumption of Cinnamomum cassia powder 1.5 g/day for6 weeks, did not improve plasma glucose levels, insulin, andcholesterol levels and no reduction in HbA1c level was noted(Vanschoonbeek et al., 2006). Only one trial by Blevins et al.observed significant increases in HbA1c and FPG levels (Blevinset al., 2007). In healthy, sedentary and obese women with Cassiasupplementation a statistically significant reduction in glucoselevel was noted suggesting that the bark of Cassiacan improveglucose tolerance. However, this study did not mention the acutedose of Cassia to maintain insulin resistance or sensitivity(Gutierrez et al., 2016). Some studies proposed that cinnamonalso improved lipid profiles in clinical trials. Vafa et al. showedthat in type 2 diabetes treated with cinnamon increased LDLlevels but decreased TC, insulin and triglyceride levels with theimproved glycemic index (Vafa et al., 2012). In addition,intercellular adhesion molecule-1 (ICAM-1) levels areincreased in serum associated with increasing type-2 diabetes.Azimi et al. studied that consumption of Cinnamomum verumextract for 8 weeks decreased serum ICAM-1 level in patientswith type-2 diabetes (Azimi et al., 2016).26 clinical trial studies on cinnamon are present on ClinicalTrials Govt. Database, among them most of the studies are underprocess and 14 studies are completed. Clinical trial numbersNCT03219411 and NCT01301521 showed effects of cinnamonsupplementation in pre-diabetic patients. Clinical trialsFrontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013917Sharifi-Rad et al. Cinnamomum SpeciesNCT03711682 and NCT00237640 observed plasma glucose andlipid levels reduction mediated by cinnamon in type 2 diabeticpatients and in noninsulin dependent type 2 diabetes mellituspatients respectively. NCT01302743 trial demonstrated theapplication of water-soluble cinnamon bark extract andmetformin for the treatment of type 2 diabetes mellituspatients. Table 3 displayed the clinical studies on Cinnamonplants in relation to diabetes.Neurodegenerative DisordersNeurodegenerative disorders (ND) include disorders likeAlzheimer\u2019s disease, amyotrophic lateral sclerosis, Parkinson\u2019sdisease, Huntington\u2019s disease, motor neuron disorder, andfrontotemporal dementia that result from slow progressive andunalterable drop of certain areas of the nervous system, leading todisruption in nervous system working or death (Nussbaum et al.,2017).Various Cinnamomum species displayed efficacy in themanagement of neurodegenerative diseases. Several in vitrostudies are present for cinnamon that can regulate factors thattrigger neurodegenerative diseases. Cinnamon extract inhibitedTau aggregation in vitro attenuating Alzheimer\u2019s diseases(Peterson et al., 2009). C. cassia bark extracted in ethanoldemonstrated in vitro efficacy against Huntington disease Kaurand Shri (2018). Therefore, cinnamon is necessary to put intoclinical trials that develop drugs for neurodegenerative disorders.One clinical trial (NCT03225144) for patients with motor neurondisorder, frontotemporal dementia, or related adult-onsetneurodegenerative disorder is ongoing involving 200participants (Table 3).Polycystic Ovary Syndrome: A PossibleControl on Its Metabolic ParametersPolycystic ovary syndrome (PCOS) is caused by an associatedendocrine dysfunction and is associated with increased risk ofdeveloping insulin resistance, type 2 diabetes, high bloodpressure, hypercholesteromy and heart disease.Several clinical trials reported conflicts in results for cinnamonefficiency on the improvement of BMI, body weight, oxidativestress, and fertility (Hajimonfarednejad et al., 2018a; Borzoeiet al., 2018b; Khan and Begum, 2019). Consumption of daily1.5 g cinnamon did not show any significant effect on BMI andbody weight but improved glucose balance in patients with PCOS(Hajimonfarednejad et al., 2018a). However, Borzoei et al.decreased BMI and improved glucose balance treated with thesame concentration as applied by Hajimonfarednejad et al.(Hajimonfarednejad et al., 2018a; Borzoei et al., 2018b). Oralsupplementation of cinnamon also showed weight loss. Thisstudy further exhibited decreased BMI in comparison to theplacebo group in PCOS patients (Talaat and Ammar, 2018;Parseh et al., 2019). In contrast to the report byHajimonfarednejad et al. and Kort and Lobo observed thatoral cinnamon consumption did not show any effect on serumglucose balance in PCOS patients (Kort and Lobo, 2014a;Hajimonfarednejad et al., 2018a). This study also supported byParseh et al., who also did not report any changes in glucosehomeostasis (Parseh et al., 2019). All of the studies discussed hereshowed an effective dose of cinnamon as 1.5 g per day, three timesafter meal for 1.5\u20136 months except Talaat and Ammar reportedeffective dose of 336 mg cinnamon extract per day whereasWiweko and Susanto (2017) treated with 200 mg ofCinnamomum burmanii and Lagerstroemia speciosacombination extract (Talaat and Ammar, 2018).Serum LDL-C, TG and TC levels were also found to beimproved in PCOS patients in comparison to placebo(Hajimonfarednejad et al., 2018a; Borzoei et al., 2018b).However, HDL-C level did not show any significantimprovement (Borzoei et al., 2018b). Khan and Begumobserved no changes in insulin resistance and did not foundany significant improvement in patients\u2019 life in comparison withmetformin treatment as a control (Khan and Begum, 2019).Herbal medicine combination extract of Glycyrrhiza glabra,Paeonia lactiflora, Cinnamomum verum and Hypericumperforatum (supplemented with 1.5 g tablet per day for3 months) with lifestyle intervention positively improvedmenstrual regulation and reduction in oligomenorrhoea of32.9% in patients in comparison with only lifestyle interventionin overweight women with PCOS (Arentz et al., 2017).Oxidative stress is one of the main causes for increasinglipogenes, BMI in PCOS due to molecular damage, andreduction of serum antioxidants. Borzoei et al. demonstratedthat cinnamon extract has antioxidant activity that can improveoxidative stress in women with PCOS (Borzoei et al., 2018a).Table 3 summarized the clinical studies on cinnamon plants inrelation to PCOS.TOXICOLOGICAL SAFETY AND ADVERSEEFFECTS OF NATURAL DERIVATIVES OFCINNAMOMUM SPECIESBesides the numerous health benefits, all phyto-therapeutics arenot always safe and might result in adverse effects such as allergicdermatitis, the toxicity of organs and interactions with foods andpharmaceuticals (Calixto, 2000). The usual dose for dietarysupplements has been suggested to be between 1 and 4 g perday (NIHU, 2015). The usual doses for the administration ofcinnamon oil, which is stronger, vary between 50 and 200 mg perday. For doses up to 6 g per day, no adverse reactions werereported (Yun et al., 2018). The common use of cinnamon in foodas a spice, food additives and flavoring agent would suggest that itis likely to be safe (Gowder, 2014). However, when consumed inexcess, cinnamon can cause respiratory distress, increase pulserate and increase the sweating process, followed by depressive anddrowsy states. This may aggravate the symptoms of rosacea andmay increase the risk of developing oral cancer. Coumarin,naturally found in cinnamon, can have a negative influence onthe liver, so people with liver disorders should avoid excessiveconsumption (Organization, 2001).Cinnamon extract at different doses didn\u2019t produce any toxicityor mortality on rats, as well as no adverse effect was observed(Ahmad et al., 2013) though trans-cinnamaldehyde and coumarinsare toxic components of cinnamon (Woehrlin et al., 2010; ZhangFrontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013918Sharifi-Rad et al. Cinnamomum Specieset al., 2010). High levels of coumarin and cinnamaldehyde mightbe correlated to liver damage (Deng, 2012), risk of cancer(Abraham et al., 2010), mouth sores (Vivas and Migliari, 2015),low blood sugar (Adisakwattana et al., 2011; Deng, 2012) breathingproblems and interaction with certain medications (Abrahamet al., 2010). Therefore, the long-term use of a high amount ofcinnamon should be continuously monitored. The tolerable dailyintake for coumarin (0.1 mg/b. w.) is to be regarded as safe in termsof daily cinnamon intake without the risk of adverse effects(Abraham et al., 2010). When used in large quantitiesCinnamomum may interact with certain drugs, which coulddamage the liver.Used externally, the cinnamon essential oil can produce skinredness, irritation and burning sensation in the epidermis(Markman, 2002). In addition, negative interactions with thedrugs such as statins, acetaminophen, amiodarone (used to treatheart conditions), carbamazepine (given in the treatment ofseizures), medicines for treating fungal infections,methotrexate (used in antitumor treatments) and methyldopa(used in hypertension) may also occur.Because cinnamon can reduce the concentration of blood sugar,consumed in large quantities, it can interact with diabetesmedicines, leading to a very low level of sugar. It is alsopossible to interfere negatively with tetracycline. Noteworthy,the safety of cinnamon is dependent on supplier qualityassurance (SQA), good manufacturing practice (GMP) andgood agricultural practice (GAP). It is necessary to control thecultivation, harvesting, plant identification, contamination,adulteration, preparation, packaging, transportation, storage etc.In order to guarantee the safety of the cinnamon products, it isrequired to assess the quality control of identity/authenticity andpurity, stability and shelf life, toxicity physical/chemical/biological/microbial properties and finally standardization of the plantmaterial as well as the products (Kumari and Kotecha, 2016).DISCUSSIONOne of the strengths of this updated review is that thepharmacological effects highlighted in preclinical in vitro studiesand in vitvo models could be translated into recent clinical trialsin human subjects at well-defined doses, providing strongscientific evidence-based support for therapeutic effects.ethnopharmacological features of cinamomum species.In addition, current toxicological data show that unwantedside effects may occur at higher doses of cinnamon than shown inpharmacological studies.Another strength of this comprehensive review is thesummarized presentation of the pharmacological mechanismsand molecular targets of action resulting from the meta-analyzesincluded in the study in order to open new clinicalpharmacotherapeutic perspectives.Starting from traditional uses, pharmacognostic research onCinnamomum plants have identified chemical compounds withbiological activities. Three major components found in cinnamonoil and powder: are cinnamaldehyde, acetate, and cinnamylalcohol, give it beneficial properties. Also, cinnamon is a goodsource of iron, calcium, manganese and dietary fiber (Vallverd\u00fa-Queralt et al., 2014).Plant organic extracts are a rich source of antimicrobial agentsand methanol extracts are known for their antimicrobialproperties. Indeed, organic solvents have a good ability tosolubilize the active components (de Boer et al., 2005) and theiruse does not influence the bioactivity of these components (Goyalet al., 2009). (Thongson et al., 2004) also suggested that organicsolvents are better solvents of antimicrobial substances. Therefore,a number of preclinical experimental studies showed theantibacterial effects of Cinnamomum plants. Secondarymetabolites of Cinnamon plants have the ability to adhere tothe microbial cell surface by crossing the lipid layer of thecytoplasmic wall, thus accumulating in the bacterial cell wall.Therefore, phytochemicals alter the structure of the membraneand increase its permeability, causing leakage of vital intracellularmetabolites and, finally, cell death (Rhayour, 2003;Wu et al., 2009).The bacterial cytoplasmic membrane plays a role in selectivepermeability by ensuring the crossing of H+ and K ions+. Themaintenance and regulation of this barrier are provided by thestructural, chemical composition of the cell wall. Increased ionleakage means a disruption of the permeability barrier. Cellmetabolism can be influenced by changes in the structuralintegrity of the cell membrane that, in turn, can lead to thedeath of cells. (Cox et al., 2001).Several preclinical experimental studies have been developedto highlight the antidiabetic effects of natural molecules fromCinnamomum species. Current conventional therapies usedin the treatment of diabetes have many limitations, such asshort- and long-term undesirable effects and high rates offailure (Sharifi-Rad et al., 2020a). Therefore, it is necessary todevelop more effective drugs to treat diabetes. Presently,complementary herbal remedies are expected to havehypoglycemic properties similar to those of conventionalmedications without troublesome side effects (Sharifi-Radet al., 2020b). Traditional herbs and spices can also delay theonset of diabetic complications, control blood sugar levelsand correct metabolic abnormalities. The in vitro methodsare essentially based on the inhibition of enzymes involved inthe carbohydrate catabolism and therefore sugar absorption.However, the determination of the in vivo antidiabeticactivity requires the development of approaches such asoral glucose tolerance test, streptozotocin (SZT)-induceddiabetes and alloxan-induced animal models.The potential mechanisms of antidiabetic effects ofCinnamomum species were highlighted by recent studies.These have shown that secondary plant metabolites, such asterpenoids and flavonoids, have a significant hypoglycemiceffect (Marles and Farnsworth, 1995). Terpenoids stimulateinsulin secretion from pancreatic \u03b2-cells (Marles andFarnsworth, 1995) whereas cinnamaldehyde has a significantlyanti-hyperglycemic effect (Subash Babu et al., 2007).The antioxidant properties of Cinnamomum plants haveextensively reported. Polar extracts of the leaves, fruits andseeds, as well as several pure compounds, exhibited relevantactivities in a variety of antioxidant assays when compared topositive controls. Cinnamon extracts and its phenolic compoundsFrontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013919Sharifi-Rad et al. Cinnamomum Speciesshowed important free radical scavenging properties by themodulation of key enzymes implicated in oxidative stress orby modulation of oxidative pathways that influence themaintaining of redox homeostasis. Cinnamon extractsenhanced ferric reducing antioxidant power (FRAP) andplasma thiol (P-SH), and decreased MDA levels. In addition,they also increased antioxidant enzyme properties such as SODand catalase (Moselhy and Ali, 2009; Roussel et al., 2009). Ourstudy also showed that Cinnamomum derivatives have a goodanti-inflammatory properties.The antitumor effects of Cinnamomum species have beenreported by several studies (Koppikar et al., 2010; Kwon et al.,2010; Wondrak et al., 2010; Daker et al., 2013). Theseantineoplastic activities were tested in vitro on several types ofhuman cancer cell lines. These studies highlighted the nextpossible anticancer mechanisms of Cinnamomum plants: 1)inhibition of tumor cells growth (Koppikar et al., 2010), 2) thecinnamon extract is a potent activator of the transcription factorNRF2 (nuclear factor erythroid 2-related factor 2) orchestratedantioxidant response in human cells (Wondrak et al., 2010), 3)cinnamaldehyde involves apoptosis mediated by the increase ofp53 and APO-19 (Fas/CD95) protein signaling pathways (Ng andWu, 2011), 4) DNA (deoxyribonucleic acid) damage (Ng andWu, 2011), v)apoptosis mediated by the tyrosinase inhibition(Chen et al., 2007; Wang et al., 2011), 6) reducing themitochondrial transmembrane potential, increasing the ratio ofcytochrome C concentration and subsequently activated caspase-9/caspase-3 (Lin et al., 2009).Recent studies showed neuroprotective effects ofCinnamomum plants and their derivatives. The aqueousextract of C. verum reduced tau aggregation and filamentformation, the markers of Alzheimer\u2019s disease (Peterson et al.,2009). From the brains of patients diagnosed with Alzheimer\u2019sdisease, the C. verum extract produced the complete disassemblyof recombinant tau filaments and caused important alteration ofthe histology of paired helical filaments isolated, even though itwas not deleterious to the normal cellular function of tau.(Peterson et al., 2009). Specifically, the proanthocyanidin, achemical constituent isolated from the C. verum extract wasobserved to be mainly responsible for this inhibitory activity(Peterson et al., 2009).Recent clinical studies have found that complementary herbaltreatments with cinnamon regulate the frequency of menstrualcycles and may reduce insulin resistance in women withpolycystic ovaries.Regarding the toxicity data, some clinical studies reported thatthe most common adverse events after cinnamon consumptionwere gastrointestinal problems in patients with diabetes(Altschuler et al., 2007; Crawford, 2009), Helicobacter infection(Nir et al., 2000), polycystic ovarian syndrome (Kort and Lobo,2014b) and seasonal allergies (Walanj et al., 2014). Dermatitis(Calnan, 1976; Ackermann et al., 2009; Isaac-Renton et al., 2015)and steatites (Miller et al., 1992; Endo and Rees, 2007) were alsoreported in some case reports. A systematic review of clinicaltrials and case reports/series on side effects associated with the useof cinnamon in humans indicated that no important differenceobtained between cinnamon treated and control group in mostcases (Food and Administration, 2005; Hajimonfarednejad et al.,2018b).Further efforts should be made to investigate futureapplications of standardized Cinnamomum plants using well-designed research.OVERALL CONCLUSIONSCinnamomum plants, its extracts and chemical constituents haveseveral activities promoting human health. Antibacterial,antidiabetic, antioxidant, anti-inflammatory, antitumor andneuroprotective activities are the most studied biologicalproperties of Cinnamomum plants. Different fromconventional therapeutic medicines, Cinnamomum species canbe daily consumed in our diet without harmful effects and maybeused as a disease-preventive agent.In general, chemical constituents of Cinnamomum plants suchas cinnamon, cinnamaldehyde, cinnamophilin and others, haveboth direct and indirect activities, i.e. antioxidant and antibacterialactivities occur by direct action on oxidant species or bacterial,whereas the antidiabetic, anticancer and anti-inflammatoryactivities occur indirectly via some yet undefined receptor-mediated mechanisms. In this present review, we have retrievedand summarized the wide applications and recent literature on thephytochemistry, bioactivity and pre-clinical and clinicalinvestigations performed on many species of the genus. Besides,a detailed account on their toxicological considerations alsoindicate their safety and efficacy for human consumption.However, since a plethora of reports exist on the plant species,details on ethnobotany, biotechnological interventions anddetailing structure-activity studies are beyond the scope andcoverage of the present attempt.Botanical research advances can improve the obtaining ofCinnamomum plants with the best phytochemical compounds.Moreover, the antimicrobial effects of Cinnamomum spp. can bepotentiated in the food industry as the development ofgreen foods.AUTHOR CONTRIBUTIONSJS-R, AD, and DC conceptualization. MM, AD, NK, SS, NE, andBH validation investigation. NC, CS, AB, and SV resources. BS,MM, AD, EV, and FL. VL, TG, AA, and CC. data curation. JS-R,AD, FL, BS, VL, CC, and DC review and editing. DC supervision.All authors: writing. All authors read and approved the finalversion and contributed equally to the article.FUNDINGThis research and article processing charges were funded by agrant of Romanian Ministry of Research and Innovation,CCCDI-UEFISCDI, (project number 61PCCDI/2018PN-III-P1-1.2-PCCDI-2017-0341), within PNCDI-III; CONICYT PIA/APOYO CCTE AFB170007.Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013920Sharifi-Rad et al. Cinnamomum SpeciesREFERENCESAbdelwahab, S. I., Zaman, F. Q., Mariod, A. A., Yaacob, M., Ahmed Abdelmageed,A. H., and Khamis, S. (2010). Chemical Composition, Antioxidant andAntibacterial Properties of the Essential Oils of Etlingera Elatior andCinnamomum Pubescens Kochummen. J. Sci. Food Agric. 90, 2682\u20132688.doi:10.1002/jsfa.4140Abraham, K., W\u00f6hrlin, F., Lindtner, O., Heinemeyer, G., and Lampen, A. (2010).Toxicology and Risk Assessment of Coumarin: Focus on Human Data. Mol.Nutr. Food Res. 54, 228\u2013239. doi:10.1002/mnfr.200900281Ackermann, L., Aalto-Korte, K., Jolanki, R., and Alanko, K. (2009). OccupationalAllergic Contact Dermatitis from Cinnamon Including One Case fromAirborne Exposure. Contact Dermatitis 60, 96\u201399. doi:10.1111/j.1600-0536.2008.01486.xAdisakwattana, S., Lerdsuwankij, O., Poputtachai, U., Minipun, A., andSuparpprom, C. (2011). Inhibitory Activity of Cinnamon Bark Species andTheir Combination Effect with Acarbose against Intestinal \u03b1-glucosidase andPancreatic \u03b1-amylase. Plant Foods Hum. Nutr. 66, 143\u2013148. doi:10.1007/s11130-011-0226-4Agarwal, H., Nakara, A., Menon, S., and Shanmugam, V. (2019). Eco-friendlySynthesis of Zinc Oxide Nanoparticles Using Cinnamomum Tamala LeafExtract and its Promising Effect towards the Antibacterial Activity. J. DrugDeliv. Sci. Tech. 53, 101212. doi:10.1016/j.jddst.2019.101212Ahmad, M., Lim, C. P., Akowuah, G. A., Ismail, N. N., Hashim, M. A., Hor, S. Y.,et al. (2013). Safety Assessment of Standardised Methanol Extract ofCinnamomum Burmannii. Phytomedicine 20, 1124\u20131130. doi:10.1016/j.phymed.2013.05.005Akilen, R., Tsiami, A., Devendra, D., and Robinson, N. (2010). GlycatedHaemoglobin and Blood Pressure-Lowering Effect of Cinnamon in Multi-Ethnic Type 2 Diabetic Patients in the UK: a Randomized, Placebo-Controlled,Double-Blind Clinical Trial. Diabetic Med. 27, 1159\u20131167. doi:10.1111/j.1464-5491.2010.03079.xAl-Bayati, F. A., and Mohammed, M. J. (2009). Isolation, Identification, andPurification of Cinnamaldehyde fromCinnamomum ZeylanicumbarkOil. An Antibacterial Study. Pharm. Biol. 47, 61\u201366. doi:10.1080/13880200802430607Al-Logmanii, A. S., and Zari, T. A. (2009). Effects of Nigella Sativa L. AndCinnamomum Zeylanicum Blume Oils on Some Physiological Parameters inStreptozotocin-Induced Diabetic Rats. Bolet\u00ednl Atino Americano y Del. Caribede Plantas Medicinales y Arom\u00e1ticas 8, 159.Alqasoumi, S. (2012). Anti-secretagogue and Antiulcer Effects of CinnamonCinnamomum Zeylanicum in Rats. J. Pharmacognosy Phytother. 4, 53\u201361.doi:10.5897/jpp12.023Altschuler, J. A., Casella, S. J., Mackenzie, T. A., and Curtis, K. M. (2007). The Effectof Cinnamon on A1C Among Adolescents with Type 1 Diabetes. Diabetes care30, 813\u2013816. doi:10.2337/dc06-1871Anand, P., Murali, K. Y., Tandon, V., Murthy, P. S., and Chandra, R. (2010).Insulinotropic Effect of Cinnamaldehyde on Transcriptional Regulation ofPyruvate Kinase, Phosphoenolpyruvate Carboxykinase, and GLUT4Translocation in Experimental Diabetic Rats. Chemico-Biological Interactions186, 72\u201381. doi:10.1016/j.cbi.2010.03.044Anderson, D., Cordell, H. J., Fakiola, M., Francis, R. W., Syn, G., Scaman, E.S. H., et al. (2015). First Genome-wide Association Study in an AustralianAboriginal Population Provides Insights into Genetic Risk Factors forBody Mass Index and Type 2 Diabetes. PloS one 10, e0119333. doi:10.1371/journal.pone.0119333Arentz, S., Smith, C. A., Abbott, J., Fahey, P., Cheema, B. S., and Bensoussan, A.(2017). Combined Lifestyle and Herbal Medicine in Overweight Women withPolycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial.Phytother. Res. 31, 1330\u20131340. doi:10.1002/ptr.5858Atta, A. H., and Alkofahi, A. (1998). Anti-nociceptive and Anti-inflammatoryEffects of Some Jordanian Medicinal Plant Extracts. J. Ethnopharmacology 60,117\u2013124. doi:10.1016/s0378-8741(97)00137-2Azimi, P., Ghiasvand, R., Feizi, A., Hosseinzadeh, J., Bahreynian, M., Hariri, M.,et al. (2016). Effect of Cinnamon, Cardamom, Saffron and GingerConsumption on Blood Pressure and a Marker of Endothelial Function inPatients with Type 2 Diabetes Mellitus: A Randomized Controlled ClinicalTrial. Blood Press. 25, 133\u2013140. doi:10.3109/08037051.2015.1111020Bakar, A., Yao, P. C., Ningrum, V., Liu, C. T., and Lee, S. C. (2020). BeneficialBiological Activities of Cinnamomum Osmophloeum and its Potential Use inthe Alleviation of Oral Mucositis: A Systematic Review. Biomedicines 8. doi:10.3390/biomedicines8010003Bandara, T., Uluwaduge, I., and Jansz, E. R. (2012). Bioactivity of Cinnamon withSpecial Emphasis on Diabetes Mellitus: a Review. Int. J. Food Sci. Nutr. 63,380\u2013386. doi:10.3109/09637486.2011.627849Barceloux, D. G. (2009). Cinnamon (Cinnamomum Species). Disease-a-Month 55,327\u2013335. doi:10.1016/j.disamonth.2009.03.003Basu, S., Jana, S., Patel, V. B., and Patel, H. (2013). Effects of Piperine, CinnamicAcid and Gallic Acid on Rosuvastatin Pharmacokinetics in Rats. Phytother Res.27, 1548\u20131556. doi:10.1002/ptr.4894Bedigian, D. (2005). Cinnamon and Cassia. The Genus Cinnamomum. Medicinaland Aromatic Plants-Industrial Profiles, Vol. 36. Econ. Bot. 3659, 93\u201394. doi:10.1663/0013-0001(2005)059Blevins, S. M., Leyva, M. J., Brown, J., Wright, J., Scofield, R. H., and Aston, C. E.(2007). Effect of Cinnamon on Glucose and Lipid Levels in Non Insulin-dependent Type 2 Diabetes. Diabetes care 30, 2236\u20132237. doi:10.2337/dc07-0098Borges, A., Ferreira, C., Saavedra, M. J., and Sim\u00f5es, M. (2013). AntibacterialActivity and Mode of Action of Ferulic and Gallic Acids against PathogenicBacteria. Microb. Drug Resist. 19, 256\u2013265. doi:10.1089/mdr.2012.0244Borzoei, A., Rafraf, M., and Asghari-Jafarabadi, M. (2018a). Cinnamon ImprovesMetabolic Factors without Detectable Effects on Adiponectin in Women withPolycystic Ovary Syndrome. Asia Pac. J. Clin. Nutr. 27, 556\u2013563. doi:10.6133/apjcn.062017.13Borzoei, A., Rafraf, M., Niromanesh, S., Farzadi, L., Narimani, F., and Doostan, F.(2018b). Effects of Cinnamon Supplementation on Antioxidant Status andSerum Lipids in Women with Polycystic Ovary Syndrome. J. traditionalComplement. Med. 8, 128\u2013133. doi:10.1016/j.jtcme.2017.04.008B\u00f6senberg, L. H., and Van Zyl, D. G. (2008). The Mechanism of Action of OralAntidiabetic Drugs: A Review of Recent Literature. J. Endocrinol. Metab.Diabetes South Africa 13, 80\u201388. doi:10.1080/22201009.2008.10872177Buga, A.-M., Docea, A. O., Albu, C., Malin, R. D., Branisteanu, D. E., Ianosi, G.,et al. (2019). Molecular and Cellular Stratagem of Brain Metastases Associatedwith Melanoma. Oncol. Lett. 17, 4170\u20134175. doi:10.3892/ol.2019.9933Buru, A. S., Pichika, M. R., Neela, V., and Mohandas, K. (2014). In vitroantibacterial Effects of Cinnamomum Extracts on Common BacteriaFound in Wound Infections with Emphasis on Methicillin-ResistantStaphylococcus aureus. J. Ethnopharmacology 153, 587\u2013595. doi:10.1016/j.jep.2014.02.044Ca\u0306lina, D., Docea, A. O., Rosu, L., Zlatian, O., Rosu, A. F., Anghelina, F., et al.(2017). Antimicrobial Resistance Development Following Surgical SiteInfections. Mol. Med. Rep. 15, 681\u2013688. doi:10.3892/mmr.2016.6034Calixto, J. B. (2000). Efficacy, Safety, Quality Control, Marketing and RegulatoryGuidelines for Herbal Medicines (Phytotherapeutic Agents). Braz. J. Med. Biol.Res. 33, 179\u2013189. doi:10.1590/s0100-879x2000000200004Calnan, C. D. (1976). Cinnamon Dermatitis from an Ointment. Contact dermatitis2, 167\u2013170. doi:10.1111/j.1600-0536.1976.tb03018.xCarson, C. F., Mee, B. J., and Riley, T. V. (2002). Mechanism of Action of MelaleucaAlternifolia (Tea Tree) Oil on Staphylococcus aureus Determined by Time-Kill,Lysis, Leakage, and Salt Tolerance Assays and Electron Microscopy. Aac 46,1914\u20131920. doi:10.1128/aac.46.6.1914-1920.2002Chakraborty, A., Sankaran, V., Sankaran, M. R., and Chellappan, D. R. (2015).Chemical Analysis of Leaf Essential Oil of Cinnamomum Verum from PalniHills, Tamil Nadu. J. Chem. Pharm. Sci. 8, 476\u2013479.Chang, C.-W., Chang, W.-L., Chang, S.-T., and Cheng, S.-S. (2008). AntibacterialActivities of Plant Essential Oils against Legionella pneumophila.Water Res. 42,278\u2013286. doi:10.1016/j.watres.2007.07.008Chang, S.-T., Chen, P.-F., and Chang, S.-C. (2001). Antibacterial Activity of LeafEssential Oils and Their Constituents from Cinnamomum Osmophloeum.J. Ethnopharmacology 77, 123\u2013127. doi:10.1016/s0378-8741(01)00273-2Chao, S. C., Young, D. G., and Oberg, C. (2000). Screening for Inhibitory Activity ofEssential Oils on Selected Bacteria, Fungi and Viruses. J. Essential Oil Res. 12(5), 639\u2013649. doi:10.1080/10412905.2000.9712177Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013921Sharifi-Rad et al. Cinnamomum SpeciesChen, C.-Y., Chen, C.-H., Lo, Y.-C., Wu, B.-N.,Wang, H.-M., Lo,W.-L., et al. (2008).Anticancer Activity of Isoobtusilactone A fromCinnamomum Kotoense:Involvement of Apoptosis, Cell-Cycle Dysregulation, Mitochondria Regulation,and Reactive Oxygen Species. J. Nat. Prod. 71, 933\u2013940. doi:10.1021/np070620eChen, C.-Y., Chen, C.-H., Wong, C.-H., Liu, Y.-W., Lin, Y.-S., Wang, Y.-D., et al.(2007). Cytotoxic Constituents of the Stems of Cinnamomum Subavenium.J. Nat. Prod. 70, 103\u2013106. doi:10.1021/np060425kChen, G., Lu, F., Xu, L., Dong, H., Yi, P., Wang, F., et al. (2013). The Anti-diabeticEffects and Pharmacokinetic Profiles of Berberine in Mice Treated with Jiao-Tai-Wan and its Compatibility. Phytomedicine 20, 780\u2013786. doi:10.1016/j.phymed.2013.03.004Chen, L., Sun, P., Wang, T., Chen, K., Jia, Q., Wang, H., et al. (2012). DiverseMechanisms of Antidiabetic Effects of the Different Procyanidin OligomerTypes of Two Different Cinnamon Species ondb/dbMice. J. Agric. Food Chem.60, 9144\u20139150. doi:10.1021/jf3024535Chen, Y., Ma, Y., and Ma, W. (2009). Pharmacokinetics and Bioavailability ofCinnamic Acid after Oral Administration of Ramulus Cinnamomi in Rats. Eur.J. Drug Metabol. Pharmacokinet. 34, 51\u201356. doi:10.1007/bf03191384Cheng, D. M., Kuhn, P., Poulev, A., Rojo, L. E., Lila, M. A., and Raskin, I. (2012). Invivo and In Vitro Antidiabetic Effects of Aqueous Cinnamon Extract andCinnamon Polyphenol-Enhanced Food Matrix. Food Chem. 135, 2994\u20133002.doi:10.1016/j.foodchem.2012.06.117Chua, M.-T., Tung, Y.-T., and Chang, S.-T. (2008). Antioxidant Activities ofEthanolic Extracts from the Twigs of Cinnamomum Osmophloeum. Bioresour.Tech. 99, 1918\u20131925. doi:10.1016/j.biortech.2007.03.020Cox, S., Mann, C., Markham, J., Gustafson, J., Warmington, J., and Wyllie, S.(2001). Determining the Antimicrobial Actions of Tea Tree Oil. Molecules 6,87\u201391. doi:10.3390/60100087Crawford, P. (2009). Effectiveness of Cinnamon for Lowering Hemoglobin A1C inPatients with Type 2 Diabetes: a Randomized, Controlled Trial. J. Am. BoardFam. Med. 22, 507\u2013512. doi:10.3122/jabfm.2009.05.080093Crews, R., Gomada, Y., Jamison, B., and Vattem, D. (2016). Molecular Effects ofCinnamon Bioactive Compounds for Neuroprotection in D. Melanogaster.FASEB J. 30, 692.Daker, M., Lin, V. Y., Akowuah, G. A., Yam, M. F., and Ahmad, M. (2013).Inhibitory Effects of Cinnamomum Burmannii Blume Stem Bark Extractand Trans-cinnamaldehyde on Nasopharyngeal Carcinoma Cells;Synergism with Cisplatin. Exp. Ther. Med. 5, 1701\u20131709. doi:10.3892/etm.2013.1041De Boer, H. J., Kool, A., Broberg, A., Mziray, W. R., Hedberg, I., and Levenfors,J. J. (2005). Anti-fungal and Anti-bacterial Activity of Some Herbal Remediesfrom Tanzania. J. Ethnopharmacology 96, 461\u2013469. doi:10.1016/j.jep.2004.09.035De Oliveira, M. M. M., Brugnera, D. F., Do Nascimento, J. A., and Piccoli, R. H.(2012). Control of Planktonic and Sessile Bacterial Cells by Essential Oils. FoodBioproducts Process. 90, 809\u2013818. doi:10.1016/j.fbp.2012.03.002Defronzo, R. A., Bonadonna, R. C., and Ferrannini, E. (1992). Pathogenesis ofNIDDM: A Balanced Overview. Diabetes Care 15, 318\u2013368. doi:10.2337/diacare.15.3.318Deng, R. (2012). A Review of the Hypoglycemic Effects of Five Commonly UsedHerbal Food Supplements. Fna 4, 50\u201360. doi:10.2174/1876142911204010050Di Pasqua, R., Betts, G., Hoskins, N., Edwards, M., Ercolini, D., and Mauriello, G.(2007). Membrane Toxicity of Antimicrobial Compounds from Essential Oils.J. Agric. Food Chem. 55, 4863\u20134870. doi:10.1021/jf0636465Eidi, A., Mortazavi, P., Bazargan, M., and Zaringhalam, J. (2012). HepatoprotectiveActivity of Cinnamon Ethanolic Extract against CCI4-Induced Liver Injury inRats. Excli j 11, 495\u2013507.Endo, H., and Rees, T. D. (2007). Cinnamon Products as a Possible Etiologic Factorin Orofacial Granulomatosis. Med. Oral Patol Oral Cir Bucal 12, E440\u2013E444.Eumkeb, G., Siriwong, S., and Thumanu, K. (2012). Synergistic Activity of Luteolinand Amoxicillin Combination against Amoxicillin-Resistant Escherichia coliand Mode of Action. J. Photochem. Photobiol. B: Biol. 117, 247\u2013253. doi:10.1016/j.jphotobiol.2012.10.006EUROPEAN SCIENTIFIC COOPERATIVE ON PHYTOTHERAPY (2003).ESCOP Monographs. 2nd ed. Amsterdam, Netherlands: World Press.Fani, M. M., and Kohanteb, J. (2011). Inhibitory Activity of Cinnamon Zeylanicumand Eucalyptus Globulus Oils on StreptococcusMutans, Staphylococcus Aureus,and Candida Species Isolated from Patients with Oral Infections. Shiraz Univ.Dent J. 11, 14\u201322.Farahpour, M., and Habibi, M. (2012). Evaluation of the Wound Healing Activityof an Ethanolic Extract of Ceylon Cinnamon in Mice. Veterinarni Medicina 57,53\u201357. doi:10.17221/4972-vetmedFood and Administration 2005. Guidance for Industry: Estimating the MaximumSafe Dose in Initial Clinical Trials for Therapeutics in Adult HealthyVolunteers. Mitochondrion 9. 9\u201316. doi:10.1016/j.mito.2008.09.002Garcez, F., Garcez, W., Martins, M., Matos, M., Guterres, Z., Mantovani, M., et al.(2005). Cytotoxic and Genotoxic Butanolides and Lignans fromAioueaTrinervis. Planta Med. 71, 923\u2013927. doi:10.1055/s-2005-871251Geng, S., Cui, Z., Huang, X., Chen, Y., Xu, D., and Xiong, P. (2011). Variations inEssential Oil Yield and Composition during Cinnamomum cassia Bark Growth.Ind. Crops Prod. 33, 248\u2013252. doi:10.1016/j.indcrop.2010.10.018Gowder, S. (2014). Safety Assessment of Food Flavor-Cinnamaldehyde. Biosafety 3,e147.Goyal, P., Chauhan, A., and Kaushik, P. (2009). Laboratory Evaluation of CrudeExtracts of Cinnamomumtamala for Potential Antibacterial Activity. Electron.J. Biol. 5, 75\u201379.Goyal, P., Khanna, A., Chauhan, A., Chauhan, G., and Kaushik, P. (2008). In vitroevaluation of Crude Extracts of Catharanthus Roseus for Potential AntibacterialActivity. Int. J. Green. Pharm. 2, 176\u2013181. doi:10.4103/0973-8258.42739Guerra, F. Q. S., Mendes, J. M., Sousa, J. P. d., Morais-Braga, M. F. B., Santos, B. H.C., Melo Coutinho, H. D., et al. (2012). Increasing Antibiotic Activity againsta Multidrug-resistantAcinetobacterspp by Essential Oils ofCitruslimonandCinnamomum Zeylanicum. Nat. Product. Res. 26, 2235\u20132238.doi:10.1080/14786419.2011.647019Gutierrez, J. L., Bowden, R. G., and Willoughby, D. S. (2016). CassiaCinnamonSupplementation Reduces Peak Blood Glucose Responses but Does NotImprove Insulin Resistance and Sensitivity in Young, Sedentary, ObeseWomen. J. Dietary Supplements 13, 461\u2013471. doi:10.3109/19390211.2015.1110222Hajimonfarednejad, M., Nimrouzi, M., Heydari, M., Zarshenas, M. M., Raee, M. J.,and Jahromi, B. N. (2018a). Insulin Resistance Improvement by CinnamonPowder in Polycystic Ovary Syndrome: A Randomized Double-Blind PlaceboControlled Clinical Trial. Phytotherapy Res. 32, 276\u2013283. doi:10.1002/ptr.5970Hajimonfarednejad, M., Ostovar, M., Raee, M. J., Hashempur, M. H., Mayer, J. G.,and Heydari, M. (2018b). Cinnamon: A Systematic Review of Adverse Events.Clin. Nutr. 38. 594\u2013602. doi:10.1016/j.clnu.2018.03.013Hameed, I., Altameme, H., andMohammed, G. (2016). Evaluation of Antifungal andAntibacterial Activity and Analysis of Bioactive Phytochemical Compounds ofCinnamomum Zeylanicum (Cinnamon Bark) Using Gas Chromatography-MassSpectrometry. Orient. J. Chem. 32, 1769\u20131788. doi:10.13005/ojc/320406Hanhineva, K., T\u00f6rr\u00f6nen, R., Bondia-Pons, I., Pekkinen, J., Kolehmainen, M.,Mykk\u00e4nen, H., et al. (2010). Impact of Dietary Polyphenols on CarbohydrateMetabolism. Ijms 11, 1365\u20131402. doi:10.3390/ijms11041365Helander, I. M., Alakomi, H.-L., Latva-Kala, K., Mattila-Sandholm, T., Pol, I., Smid,E. J., et al. (1998). Characterization of the Action of Selected Essential OilComponents on Gram-Negative Bacteria. J. Agric. Food Chem. 46, 3590\u20133595.doi:10.1021/jf980154mHo, S.-C., Chang, K.-S., and Chang, P.-W. (2013). Inhibition ofNeuroinflammation by Cinnamon and its Main Components. Food Chem.138, 2275\u20132282. doi:10.1016/j.foodchem.2012.12.020Hu, F. B. (2011). Globalization of Diabetes: the Role of Diet, Lifestyle, and Genes.Diabetes Care 34, 1249\u20131257. doi:10.2337/dc11-0442Hu, T. W., Lin, Y. T., and Ho, C. K. (1985). Natural Variation ofChemicalcomponents of the Leaf Oil of Cinnamomum OsmophloeumKaneh. Bull. Taiwan For. Res. Instustry New Ser. 78, 18.Huang, D. F., Xu, J.-G., Liu, J.-X., Zhang, H., and Hu, Q. P. (2014). ChemicalConstituents, Antibacterial Activity and Mechanism of Action of the EssentialOil from Cinnamomum cassia Bark against Four Food-Related Bacteria.Microbiology 83, 357\u2013365. doi:10.1134/s0026261714040067Isaac-Renton, M., Li, M. K., and Parsons, L. M. (2015). Cinnamon Spiceand Everything Not Nice. Dermatitis 26, 116\u2013121. doi:10.1097/der.0000000000000112Jain, S., Sangma, T., Shukla, S. K., and Mediratta, P. K. (2015). EffectofCinnamomum Zeylanicumextract on Scopolamine-Induced CognitiveFrontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013922Sharifi-Rad et al. Cinnamomum SpeciesImpairment and Oxidative Stress in Rats. Nutr. Neurosci. 18, 210\u2013216. doi:10.1179/1476830514y.0000000113Jang, H.-D., Chang, K.-S., Huang, Y.-S., Hsu, C.-L., Lee, S.-H., and Su, M.-S. (2007).Principal Phenolic Phytochemicals and Antioxidant Activities of Three ChineseMedicinal Plants. Food Chem. 103, 749\u2013756. doi:10.1016/j.foodchem.2006.09.026Jantan, I. B., and Goh, S. H. (1992). Essential Oils ofCinnamomumSpecies fromPeninsular Malaysia. J. Essent. Oil Res. 4, 161\u2013171. doi:10.1080/10412905.1992.9698038Jantan, I. B., Yalvema, M. F., Ayop, N., and Ahmad, A. S. (2005). Constituents ofthe Essential Oils ofCinnamomum Sintoc Blume from a Mountain Forest ofPeninsular Malaysia. Flavour Fragr. J. 20, 601\u2013604. doi:10.1002/ffj.1495Jantan, I., Ling, Y. E., Romli, S., Ayop, N., and Ahmad, A. S. (2003). A ComparativeStudy of the Constituents of the Essential Oils of ThreeCinnamomumSpeciesfrom Malaysia. J. Essent. Oil Res. 15, 387\u2013391. doi:10.1080/10412905.2003.9698618Javed, I., Faisal, I., Rahman, Z., Khan, M. Z., Muhammad, F., Aslam, B., et al.(2012). Lipid Lowering Effect of Cinnamomum Zeylanicum inHyperlipidaemic Albino Rabbits. Pak J. Pharm. Sci. 25, 141\u2013147.Jayaprakasha, G. K., Jagan Mohan Rao, L., and Sakariah, K. K. (2003). VolatileConstituents fromCinnamomum zeylanicumFruit Stalks and TheirAntioxidant Activities. J. Agric. Food Chem. 51, 4344\u20134348. doi:10.1021/jf034169iJayaprakasha, G. K., Ohnishi-Kameyama, M., Ono, H., Yoshida, M., andJaganmohan Rao, L. (2006). Phenolic Constituents in the FruitsofCinnamomum Zeylanicumand Their Antioxidant Activity. J. Agric. FoodChem. 54, 1672\u20131679. doi:10.1021/jf052736rJia, Q., Liu, X., Wu, X., Wang, R., Hu, X., Li, Y., et al. (2009). Hypoglycemic Activityof a Polyphenolic Oligomer-Rich Extract of Cinnamomum Parthenoxylon Barkin Normal and Streptozotocin-Induced Diabetic Rats. Phytomedicine 16,744\u2013750. doi:10.1016/j.phymed.2008.12.012Jiao, L., Zhang, X., Huang, L., Gong, H., Cheng, B., Sun, Y., et al. (2013).Proanthocyanidins Are the Major Anti-diabetic Components of CinnamonWater Extract. Food Chem. Toxicol. 56, 398\u2013405. doi:10.1016/j.fct.2013.02.049Kahn, S. E., Hull, R. L., and Utzschneider, K. M. (2006). Mechanisms LinkingObesity to Insulin Resistance and Type 2 Diabetes.Nature 444, 840\u2013846. doi:10.1038/nature05482Kamath, J. V., Rana, A. C., and Roy Chowdhury, A. (2003). Pro-healing EffectofCinnamomum Zeylanicum Bark. Phytother. Res. 17, 970\u2013972. doi:10.1002/ptr.1293Kamble, S., and Rambhimaiah, S. (2015). Antidiabetic Activity of Aqueous Extractof Cinnamomum cassia in Alloxan-Induced Diabetic Rats. Biomed. Pharmacol.J. 6, 83\u201388.Kang, B.-H., Racicot, K., Pilkenton, S. J., and Apostolidis, E. (2014).Evaluation of the In Vitro Anti-hyperglycemic Effect of Cinnamomumcassia Derived Phenolic Phytochemicals, via Carbohydrate HydrolyzingEnzyme Inhibition. Plant Foods Hum. Nutr. 69, 155\u2013160. doi:10.1007/s11130-014-0415-zKannappan, S., Jayaraman, T., Rajasekar, P., Ravichandran, M. K., and Anuradha,C. V. (2006). Cinnamon Bark Extract Improves Glucose Metabolism and LipidProfile in the Fructose-Fed Rat. Singapore Med. J. 47, 858\u2013863.Kar, A., Choudhary, B. K., and Bandyopadhyay, N. G. (2003). ComparativeEvaluation of Hypoglycaemic Activity of Some Indian Medicinal Plants inAlloxan Diabetic Rats. J. Ethnopharmacology 84, 105\u2013108. doi:10.1016/s0378-8741(02)00144-7Kaul, P. N., Bhattacharya, A. K., Rajeswara Rao, B. R., Syamasundar, K. V., andRamesh, S. (2003). Volatile Constituents of Essential Oils Isolated fromDifferent Parts of Cinnamon (Cinnamomum Zeylanicum Blume). J. Sci.Food Agric. 83, 53\u201355. doi:10.1002/jsfa.1277Kaur, R., and Shri, R. (2018). Role of the Genus Cinnamomum in the Managementof Neurodegenerative Diseases: Outcomes and Shortcomings. Indian J. Pharm.Sci. 80 (6), 984\u2013995. doi:10.4172/pharmaceutical-sciences.1000448Khan, A. A., and Begum, W. (2019). Efficacy of Darchini in the Management ofPolycystic Ovarian Syndrome: A Randomized Clinical Study. J. Herbal Med. 15,100249. doi:10.1016/j.hermed.2018.11.005Khan, A., Safdar, M., Ali Khan, M. M., Khattak, K. N., and Anderson, R. A. (2003).Cinnamon Improves Glucose and Lipids of People with Type 2 Diabetes.Diabetes care 26, 3215\u20133218. doi:10.2337/diacare.26.12.3215Kim, D. H., Kim, C. H., Kim, M.-S., Kim, J. Y., Jung, K. J., Chung, J. H., et al. (2007).Suppression of Age-Related Inflammatory NF-\u039ab Activation byCinnamaldehyde. Biogerontology 8, 545\u2013554. doi:10.1007/s10522-007-9098-2Kim, H.-O., Park, S.-W., and Park, H.-D. (2004). Inactivation of Escherichia coliO157:H7 by Cinnamic Aldehyde Purified from Cinnamomum cassia Shoot.Food Microbiol. 21, 105\u2013110. doi:10.1016/s0740-0020(03)00010-8Kim, S. H., Hyun, S. H., and Choung, S. Y. (2006). Antioxidative EffectsofCinnamomi cassiaeandRhodiola Roseaextracts in Liver of Diabetic Mice.Biofactors 26, 209\u2013219. doi:10.1002/biof.5520260306King, H., Aubert, R. E., and Herman, W. H. (1998). Global Burden of Diabetes,1995-2025: Prevalence, Numerical Estimates, and Projections.Diabetes Care 21,1414\u20131431. doi:10.2337/diacare.21.9.1414Koppikar, S. J., Choudhari, A. S., Suryavanshi, S. A., Kumari, S., Chattopadhyay, S.,and Kaul-Ghanekar, R. (2010). Aqueous Cinnamon Extract (ACE-C) from theBark of Cinnamomum cassia Causes Apoptosis in Human Cervical Cancer CellLine (SiHa) through Loss of Mitochondrial Membrane Potential. BMC Cancer10, 210. doi:10.1186/1471-2407-10-210Kort, D. H., and Lobo, R. A. (2014a). Preliminary Evidence that CinnamonImproves Menstrual Cyclicity in Women with Polycystic Ovary Syndrome:a Randomized Controlled Trial. Am. J. Obstet. Gynecol. 211, 487\u2013496. doi:10.1016/j.ajog.2014.05.009e1Krishnakumar, I. M., Abin, I., Johannah, N. M., Eapen, N., Balu, M., andRamadassan, K. (2014). Effects of the Polyphenol Content on the Anti-diabetic Activity of Cinnamomum Zeylanicum Extracts. Food Funct. 5,2208\u20132220.Kumar, S., Vasudeva, N., and Sharma, S. (2012). GC-MS Analysis and Screening ofAntidiabetic, Antioxidant and Hypolipidemic Potential of CinnamomumTamala Oil in Streptozotocin Induced Diabetes Mellitus in Rats. Cardiovasc.Diabetol. 11, 95. doi:10.1186/1475-2840-11-95Kumari, R., and Kotecha, M. (2016). A Review on the Standardization of HerbalMedicines. Int. J. Pharm. Sci. Res. 7, 97\u2013106. doi:10.7897/2230-8407.07319Kuo, S.-Y., Hsieh, T.-J., Wang, Y.-D., Lo, W.-L., Hsui, Y.-R., and Chen, C.-Y.(2008). Cytotoxic Constituents from the Leaves of Cinnamomum Subavenium.Chem. Pharm. Bull. 56, 97\u2013101. doi:10.1248/cpb.56.97Kwon, H.-K., Hwang, J.-S., So, J.-S., Lee, C.-G., Sahoo, A., Ryu, J.-H., et al. (2010).Cinnamon Extract Induces Tumor Cell Death through Inhibition of NF\u03baB andAP1. BMC cancer 10, 392. doi:10.1186/1471-2407-10-392Lambert, R. J. W., Skandamis, P. N., Coote, P. J., and Nychas, G.-J. E. (2001). AStudy of the Minimum Inhibitory Concentration and Mode of Action ofOregano Essential Oil, Thymol and Carvacrol. J. Appl. Microbiol. 91,453\u2013462. doi:10.1046/j.1365-2672.2001.01428.xLatta, C. H., Brothers, H. M., and Wilcock, D. M. (2015). Neuroinflammationin Alzheimer\u2019s Disease; A Source of Heterogeneity and Target forPersonalized Therapy. Neuroscience 302, 103\u2013111. doi:10.1016/j.neuroscience.2014.09.061Lee, H.-S., and Ahn, Y.-J. (1998). Growth-Inhibiting Effects ofCinnamomumcassiaBark-Derived Materials on Human Intestinal Bacteria. J. Agric. FoodChem. 46, 8\u201312. doi:10.1021/jf970548yLee, H. J., Hyun, E.-A., Yoon, W. J., Kim, B. H., Rhee, M. H., Kang, H. K., et al.(2006). In vitro anti-inflammatory and Anti-oxidative Effects of CinnamomumCamphora Extracts. J. Ethnopharmacology 103, 208\u2013216. doi:10.1016/j.jep.2005.08.009Lee, M.-G., Kuo, S.-Y., Yen, S.-Y., Hsu, H.-F., Leung, C.-H., Ma, D.-L., et al. (2015).Evaluation of Cinnamomum Osmophloeum Kanehira Extracts on TyrosinaseSuppressor, Wound Repair Promoter, and Antioxidant. Scientific World J. 7.303415. doi:10.1155/2015/303415Leela, N. K. (2008). \u201cCinnamon and cassia,\u201d in Chemistry of Spices. EditorsV. A. PARTHASARATHY, B. CHEMPAKAM, and T. J. ZACHARIAH(Wallingford, Oxfordshire, UK: CAB International).Leiter, L., and Lewanczuk, R. (2005). Of the Renin-Angiotensin System andReactive Oxygen speciesType 2 Diabetes and Angiotensin II Inhibition. Am.J. Hypertens. 18, 121\u2013128. doi:10.1016/j.amjhyper.2004.07.001Li, L., Li, Z. W., Yin, Z. Q., Wei, Q., Jia, R. Y., Zhou, L. J., et al. (2014). AntibacterialActivity of Leaf Essential Oil and its Constituents from CinnamomumLongepaniculatum. Int. J. Clin. Exp. Med. 7, 1721\u20131727.Liao, B.-C., Hsieh, C.-W., Liu, Y.-C., Tzeng, T.-T., Sun, Y.-W., and Wung, B.-S.(2008). Cinnamaldehyde Inhibits the Tumor Necrosis Factor-\u03b1-InducedExpression of Cell Adhesion Molecules in Endothelial Cells by SuppressingFrontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013923Sharifi-Rad et al. Cinnamomum SpeciesNF-\u039ab Activation: Effects upon I\u03baB and Nrf2. Toxicol. Appl. Pharmacol. 229,161\u2013171. doi:10.1016/j.taap.2008.01.021Liao, J.-C., Deng, J.-S., Chiu, C.-S., Hou, W.-C., Huang, S.-S., Shie, P.-H., et al.(2012a). Anti-inflammatory Activities of Cinnamomum cassia Constituents InVitro and In Vivo. Evidence-Based Complement. Altern. Med. 2012, 429320.doi:10.1155/2012/429320Liao, J. C., Deng, J. S., Chiu, C. S., Hou, W. C., Huang, S. S., Shie, P. H., et al.(2012b). Anti-Inflammatory Activities of Cinnamomum cassia Constituents InVitro and In Vivo. Evid. Based Complement. Alternat Med. 2012, 429320. doi:10.1155/2012/429320Lin, C.-C., Wu, S.-J., Chang, C.-H., and Ng, L.-T. (2003). Antioxidant ActivityofCinnamomum cassia. Phytother. Res. 17, 726\u2013730. doi:10.1002/ptr.1190Lin, G.-M., Chen, Y.-H., Yen, P.-L., and Chang, S.-T. (2016). Antihyperglycemicand Antioxidant Activities of Twig Extract fromCinnamomumOsmophloeum.J. Traditional Complement. Med. 6, 281\u2013288. doi:10.1016/j.jtcme.2015.08.005Lin, K., Yeh, S., Lin, M., Shih, M., Yang, K., and Hwang, S. (2007). MajorChemotypes and Antioxidative Activity of the Leaf Essential Oils ofCinnamomum Osmophloeum Kaneh. From a Clonal Orchard. Food Chem.105, 133\u2013139. doi:10.1016/j.foodchem.2007.03.051Lin, R.-J., Cheng, M.-J., Huang, J.-C., Lo, W.-L., Yeh, Y.-T., Yen, C.-M., et al.(2009). Cytotoxic Compounds from the Stems ofCinnamomum Tenuifolium.J. Nat. Prod. 72, 1816\u20131824. doi:10.1021/np900225pLoy, G., Cottiglia, F., Garau, D., Deidda, D., Pompei, R., and Bonsignore, L. (2001).Chemical Composition and Cytotoxic and Antimicrobial Activity ofCalycotome Villosa (Poiret) Link Leaves. Il Farmaco 56, 433\u2013436. doi:10.1016/s0014-827x(01)01056-4Lu, Z., Jia, Q., Wang, R., Wu, X., Wu, Y., Huang, C., et al. (2011). HypoglycemicActivities of A- and B-type Procyanidin Oligomer-Rich Extracts from DifferentCinnamon Barks. Phytomedicine 18, 298\u2013302. doi:10.1016/j.phymed.2010.08.008Luscher, T. F., and Steffel, J. (2008). Sweet and Sour. Circ. Res. 102, 9\u201311. doi:10.1161/01.res.0000303937.73170.31Mamindla, S., Srgp Koganti, V., Ravouru, N., and Koganti, B. (2017). Effect ofCinnamomum cassia on the Pharmacokinetics and Pharmacodynamics ofPioglitazone. Curr. Clin. Pharmacol. 12, 41\u201349. doi:10.2174/1574884712666170207152020Mang, B., Wolters, M., Schmitt, B., Kelb, K., Lichtinghagen, R., Stichtenoth, D. O.,et al. (2006). Effects of a Cinnamon Extract on Plasma Glucose, HbA1c, andSerum Lipids in Diabetes Mellitus Type 2. Eur. J. Clin. Invest. 36, 340\u2013344.doi:10.1111/j.1365-2362.2006.01629.xMarkman, M. (2002). Safety Issues in Using Complementary and AlternativeMedicine. J. Clin. Oncol. 20, 39S\u201341S.Marles, R. J., and Farnsworth, N. R. (1995). Antidiabetic Plants and Their ActiveConstituents. Phytomedicine 2, 137\u2013189. doi:10.1016/s0944-7113(11)80059-0Mathew, S., and Abraham, T. E. (2006). Studies on the Antioxidant Activities ofCinnamon (Cinnamomum Verum) Bark Extracts, through Various In VitroModels. Food Chem. 94, 520\u2013528. doi:10.1016/j.foodchem.2004.11.043Mbwambo, Z. H., Moshi, M. J., Masimba, P. J., Kapingu, M. C., and Nondo, R. S.(2007). Antimicrobial Activity and Brine Shrimp Toxicity of Extracts ofTerminalia Brownii Roots and Stem. BMC Complement. Altern. Med. 7, 9.doi:10.1186/1472-6882-7-9Miller, R. L., Gould, A. R., and Bernstein, M. L. (1992). Cinnamon-inducedStomatitis Venenata. Oral Surg. Oral Med. Oral Pathol. 73, 708\u2013716. doi:10.1016/0030-4220(92)90016-jMishra, A., Bhatti, R., Singh, A., and Singh Ishar, M. (2010). AmeliorativeEffect of the Cinnamon Oil fromCinnamomum Zeylanicumupon EarlyStage Diabetic Nephropathy. Planta Med. 76, 412\u2013417. doi:10.1055/s-0029-1186237Moselhy, S. S., and Ali, H. K. (2009). Hepatoprotective Effect of Cinnamon Extractsagainst Carbon Tetrachloride Induced Oxidative Stress and Liver Injury in Rats.Biol. Res. 42, 93\u201398. doi:10.4067/s0716-97602009000100009Ng, L. T., and Wu, S. J. (2011). Antiproliferative Activity of Cinnamomum cassiaConstituents and Effects of Pifithrin-Alpha on Their Apoptotic SignalingPathways in Hep G2 Cells. Evid. Based Complement. Alternat Med. 2011,492148. doi:10.1093/ecam/nep220Nihu, S. (2015).Department of Health and Human Services Herbs at a Glance. USA:Cinnamon NIH.Nir, Y., Potasman, I., Stermer, E., Tabak, M., and Neeman, I. (2000). ControlledTrial of the Effect of Cinnamon Extract on Helicobacter pylori. Helicobacter 5,94\u201397. doi:10.1046/j.1523-5378.2000.00014.xNoudeh, G. D., Sharififar, F., Noodeh, A. D., Moshafi, M. H., Afzadi, M. A.,Behravan, E., et al. (2010). Antitumor and Antibacterial Activity of FourFractions from Heracleumpersicum Desf. And Cinnamomum ZeylanicumBlume. J. Med. Plants Res. 4, 2176\u20132180.Nussbaum, L., Hogea, L. M., Ca\u0306lina, D., Andreescu, N., Gra\u0306dinaru, R., S,tefa\u0306nescu, R.,et al. (2017). Modern Treatment Approaches in Psychoses. Pharmacogenetic,Neuroimagistic and Clinical Implications. Farmacia 65, 75\u201381.Nyadjeu, P., Dongmo, A., Nguelefack, T. B., and Kamanyi, A. (2011).Antihypertensive and Vasorelaxant Effects of Cinnamomum ZeylanicumStem Bark Aqueous Extract in Rats. J. Complement. Integr. Med. 8. doi:10.2202/1553-3840.1490Ooi, L. S. M., Li, Y., Kam, S.-L., Wang, H., Wong, E. Y. L., and Ooi, V. E. C. (2006).Antimicrobial Activities of Cinnamon Oil and Cinnamaldehyde from theChinese Medicinal HerbCinnamomum cassiaBlume. Am. J. Chin. Med. 34,511\u2013522. doi:10.1142/s0192415x06004041ORGANIZATION (2001). Joint FAO/WHO Expert Committee on FoodAdditives. Safety evaluation of certain food additives and contaminants infood: Fumonisins. Proceedings of the 56th Meeting of the Joint FAO/WHOExpert Committee on Food Additives, 103\u2013279.Ortiz-Andrade, R. R., Garc\u00eda-Jim\u00e9nez, S., Castillo-Espa\u00f1a, P., Ram\u00edrez-\u00c1vila, G.,Villalobos-Molina, R., and Estrada-Soto, S. (2007). \u03b1-Glucosidase InhibitoryActivity of the Methanolic Extract from Tournefortia Hartwegiana: An Anti-hyperglycemic Agent. J. Ethnopharmacology 109, 48\u201353. doi:10.1016/j.jep.2006.07.002Oussalah, M., Caillet, S., Saucier, L., and Lacroix, M. (2006). Antimicrobial Effectsof Selected Plant Essential Oils on the Growth of a Pseudomonas Putida StrainIsolated from Meat. Meat Sci. 73, 236\u2013244. doi:10.1016/j.meatsci.2005.11.019Padureanu, R., Albu, C. V., Mititelu, R. R., Bacanoiu, M. V., Docea, A. O., Calina,D., et al. (2019). Oxidative Stress and Inflammation Interdependence inMultiple Sclerosis. Jcm 8, 1815. doi:10.3390/jcm8111815Panickar, K. S., Polansky, M. M., and Anderson, R. A. (2009). CinnamonPolyphenols Attenuate Cell Swelling and Mitochondrial DysfunctionFollowing Oxygen-Glucose Deprivation in Glial Cells. Exp. Neurol. 216,420\u2013427. doi:10.1016/j.expneurol.2008.12.024Panickar, K. S., Polansky, M.M., Graves, D. J., Urban, J. F., JR., and Anderson, R. A.(2012). A Procyanidin Type A Trimer from Cinnamon Extract Attenuates GlialCell Swelling and the Reduction in Glutamate Uptake Following Ischemia-likeInjury In Vitro. Neuroscience 202, 87\u201398. doi:10.1016/j.neuroscience.2011.11.051Parseh, S., Shakerian, S., and Alizadeh, A. A. (2019). Effect of Chronic Aerobic/Resistive Exercises with Supplementation of Cinnamon on Insulin Resistance inWomen with Polycystic Ovary Syndrome in Ahvaz City in 2017. J. Arak Univ.Med. Sci. 22, 15\u201326.Peng, X., Cheng, K.-W., Ma, J., Chen, B., Ho, C.-T., Lo, C., et al. (2008). CinnamonBark Proanthocyanidins as Reactive Carbonyl Scavengers to Prevent theFormation of Advanced Glycation Endproducts. J. Agric. Food Chem. 56,1907\u20131911. doi:10.1021/jf073065vPeterson, D. W., George, R. C., Scaramozzino, F., Lapointe, N. E., Anderson, R. A.,Graves, D. J., et al. (2009). Cinnamon Extract Inhibits Tau AggregationAssociated with Alzheimer\u2019s Disease In Vitro. Jad 17, 585\u2013597. doi:10.3233/jad-2009-1083Prasad, K. N., Yang, B., Dong, X., Jiang, G., Zhang, H., Xie, H., et al. (2009). FlavonoidContents and Antioxidant Activities from Cinnamomum Species. InnovativeFood Sci. Emerging Tech. 10, 627\u2013632. doi:10.1016/j.ifset.2009.05.009Pyo, J.-H., Jeong, Y.-K., Yeo, S., Lee, J.-H., Jeong, M.-Y., Kim, S.-H., et al. (2013).Neuroprotective Effect of Trans-cinnamaldehyde on the 6-Hydroxydopamine-Induced Dopaminergic Injury. Biol. Pharm. Bull. 36, 1928\u20131935. doi:10.1248/bpb.b13-00537Qin, B., Panickar, K. S., and Anderson, R. A. (2014). Cinnamon PolyphenolsRegulate S100\u03b2, Sirtuins, and Neuroactive Proteins in Rat C6 Glioma Cells.Nutrition 30, 210\u2013217. doi:10.1016/j.nut.2013.07.001Qin, B., Panickar, K. S., and Anderson, R. A. (2010). Cinnamon: Potential Role in thePrevention of Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes.J. Diabetes Sci. Technol. 4, 685\u2013693. doi:10.1177/193229681000400324Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013924Sharifi-Rad et al. Cinnamomum SpeciesRadhia, K., Zakkia, K., and Shah, S. H. (2010). Cinnamon May Reduce Glucose,Lipid and Cholesterol Level in Type 2 Diabetic Individuals. Pakistan J. Nutr. 9,430\u2013433.Raina, V. K., Srivastava, S. K., Aggarwal, K. K., Ramesh, S., and Kumar, S. (2001).Essential Oil Composition ofCinnamomum Zeylanicum Blume Leaves fromLittle Andaman, India. Flavour Fragr. J. 16, 374\u2013376. doi:10.1002/ffj.1016Rajbir, B., Kaur, S., and Singh, J.ISHARMPS (2009). Ameliorative Effect of VolatileOil from Cinnamomum Zeylanicum on Hyperalgesia in Alloxan Diabetic Rats.Can. J. Pure Applsci 3, 887\u2013895.Rameshkumar, K. B., George, V., and Shiburaj, S. (2007). Chemical Constituentsand Antibacterial Activity of the Leaf Oil ofCinnamomumchemungianumMohan et Henry. J. Essent. Oil Res. 19, 98\u2013100. doi:10.1080/10412905.2007.9699238Ranasinghe, P., Jayawardana, R., Galappaththy, P., Constantine, G. R., De VasGunawardana, N., and Katulanda, P. (2012). Efficacy and Safety of \u2019true\u2019cinnamon(Cinnamomum Zeylanicum)as a Pharmaceutical Agent inDiabetes: a Systematic Review and Meta-Analysis. Diabet Med. 29,1480\u20131492. doi:10.1111/j.1464-5491.2012.03718.xRanilla, L. G., Kwon, Y.-I., Apostolidis, E., and Shetty, K. (2010). PhenolicCompounds, Antioxidant Activity and In Vitro Inhibitory Potential againstKey Enzymes Relevant for Hyperglycemia and Hypertension of CommonlyUsed Medicinal Plants, Herbs and Spices in Latin America. Bioresour. Tech.101, 4676\u20134689. doi:10.1016/j.biortech.2010.01.093Ranjbar, A., Ghaseminejhad, S., Takalu, H., Baiaty, A., Rahimi, F., and Abdollahi,M. (2007). Anti Oxidative Stress Potential of Cinnamon (CinnamomumZeylanicum) in Operating Room Personnel; A Before/After Cross SectionalClinical Trial. Int. J. Pharmacol. 3, 482\u2013486.Rao, H. J.LAKSHMI (2012). Anti-diarrhoeal Activity of the Aqueous Extract of theBark of Cinnamomum Zeylanicum Linn in Mice. J. Clin. Diag Res. 6, 215\u2013219.Rao, P. V., and Gan, S. H. (2014). Cinnamon: A Multifaceted Medicinal Plant.Evidence-Based Complement. Altern. Med. 2014, 642942. doi:10.1155/2014/642942Rasheed, M. U., and Thajuddin, N. (2011). Effect of Medicinal Plants on MoraxellaCattarhalis. Asian Pac. J. Trop. Med. 4, 133\u2013136. doi:10.1016/S1995-7645(11)60053-9Rashidi, M., Malekirad, A. A., Abdollahi, M., Habibollahi, S., Dolatyari, N., andNarimani, M. (2014). The Effect of Tea-Cinnamon and Melissa Officinalis L.Aqueous Extraction, on Neuropsychology Distress, Biochemical and OxidativeStress Biomarkers in Glass Production Workers. Health 06, 2592\u20132601. doi:10.4236/health.2014.619298Ravindran, P., Nirmal-Babu, K., and Shylaja, M. (2003). Cinnamon and cassia: TheGenus Cinnamomum. CRC Press.Rhayour, K., Bouchikhi, T., Tantaoui-Elaraki, A., Sendide, K., and Remmal,A. (2003). The Mechanism of Bactericidal Action of Oregano and CloveEssential Oils and of Their Phenolic Major Components onEscherichiacoliandBacillus Subtilis. J. Essent. Oil Res. 15 (4), 286\u2013292. doi:10.1080/10412905.2003.9712144Ribeiro-Santos, R., Andrade, M., Madella, D., Martinazzo, A. P., de Aquino GarciaMoura, L., De Melo, N. R., et al. (2017). Revisiting an Ancient Spice withMedicinal Purposes: Cinnamon. Trends Food Sci. Tech. 62, 154\u2013169. doi:10.1016/j.tifs.2017.02.011Rogoveanu, O. C., Calina, D., Cucu, M. G., Burada, F., Docea, A. O., Sosoi, S., et al.(2018). Association of Cytokine Gene Polymorphisms with OsteoarthritisSusceptibility. Exp. Ther. Med. 16, 2659\u20132664. doi:10.3892/etm.2018.6477Ross, M. S. F. (1976). Analysis of Cinnamon Oils by High-Pressure LiquidChromatography. J. Chromatogr. A 118, 273\u2013275. doi:10.1016/s0021-9673(00)81222-4Rossi, C., Chaves-L\u00f3pez, C., Moz\u030cina, S. S., Di Mattia, C., Scuota, S., Luzzi, I., et al.(2019). Salmonella enterica Adhesion: Effect of Cinnamomum ZeylanicumEssential Oil on Lettuce. LWT 111, 16\u201322. doi:10.1016/j.lwt.2019.05.026Roussel, A.-M., Hininger, I., Benaraba, R., Ziegenfuss, T. N., and Anderson, R. A.(2009). Antioxidant Effects of a Cinnamon Extract in People with ImpairedFasting Glucose that Are Overweight or Obese. J. Am. Coll. Nutr. 28, 16\u201321.doi:10.1080/07315724.2009.10719756Russell, A. D. (2002). Antibiotic and Biocide Resistance in Bacteria: Introduction.J. Appl. Microbiol. 92 (Suppl. l), 1s\u20133s. doi:10.1046/j.1365-2672.92.5s1.14.xSadeghi, S., Davoodvandi, A., Pourhanifeh, M. H., Sharifi, N., Arefnezhad, R.,Sahebnasagh, R., et al. (2019). Anti-cancer Effects of Cinnamon: Insights into itsApoptosis Effects. Eur. J. Med. Chem. 178, 131\u2013140. doi:10.1016/j.ejmech.2019.05.067Salehi, B., Capanoglu, E., Adrar, N., Catalkaya, G., Shaheen, S., Jaffer, M., et al.(2019a). Cucurbits Plants: A Key Emphasis to its Pharmacological Potential.Molecules 24, 1854. doi:10.3390/molecules24101854Salehi, B., Jornet, P. L., Lopez, E. P. F., Calina, D., Sharifi-Rad, M., Ramirez-Alarcon, K., et al. (2019b). Plant-Derived Bioactives in Oral Mucosal Lesions: AKey Emphasis to Curcumin, Lycopene, Chamomile, Aloe Vera, Green Tea andCoffee Properties. Biomolecules 9, 23. doi:10.3390/biom9030106Salehi, B., Rescigno, A., Dettori, T., Calina, D., Docea, A. O., Singh, L., et al. (2020a).Avocado-Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited.Biomolecules 10, 130. doi:10.3390/biom10010130Salehi, B., Sharifi-Rad, J., Capanoglu, E., Adrar, N., Catalkaya, G., Shaheen, S., et al.(2019c). Cucurbita Plants: From Farm to Industry. Appl. Sci. 9, 3387. doi:10.3390/app9163387Salehi, B., Sharifi-Rad, J., Cappellini, F., Reiner, A., Zorzan, D., Imran, M., et al.(2020b). The Therapeutic Potential of Anthocyanins: Current ApproachesBased on Their Molecular Mechanism of Action. Front. Pharmacol. 11, 20.doi:10.3389/fphar.2020.01300Salehi, B., Shivaprasad Shetty, M., V. Anil Kumar, N., Z\u030civkovic\u0301, J., Calina, D., OanaDocea, A., et al. (2019d). Veronica Plants-Drifting from Farm to TraditionalHealing, Food Application, and Phytopharmacology. Molecules 24, 2454.doi:10.3390/molecules24132454Samarasekera, R., Kalhari, K. S., and Weerasinghe, I. S. (2005). MosquitocidalActivity of Leaf and Bark Essential Oils of CeylonCinnamomum Zeylanicum.J. Essent. Oil Res. 17, 301\u2013303. doi:10.1080/10412905.2005.9698909Senanayake, U. M., Lee, T. H., and Wills, R. B. H. (1978). Volatile Constituents ofCinnamon (Cinnamomum Zeylanicum) Oils. J. Agric. Food Chem. 26, 822\u2013824.doi:10.1021/jf60218a031Shan, B., Cai, Y.-Z., Brooks, J. D., and Corke, H. (2007). Antibacterial Propertiesand Major Bioactive Components of Cinnamon Stick (CinnamomumBurmannii): Activity against Foodborne Pathogenic Bacteria. J. Agric. FoodChem. 55, 5484\u20135490. doi:10.1021/jf070424dSharifi-Rad, J., Rodrigues, C. F., Sharopov, F., Docea, A. O., Karaca, A. C., Sharifi-Rad, M., et al. (2020a). Diet, Lifestyle and Cardiovascular Diseases: LinkingPathophysiology to Cardioprotective Effects of Natural Bioactive Compounds.Int. J. Environ. Res. Public Health 17, 31. doi:10.3390/ijerph17072326Sharifi-Rad, M., Kumar, N. V. A., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E.,et al. (2020b). Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth inthe Pathophysiology of Chronic Diseases. Front. Physiol. 11, 21. doi:10.3389/fphys.2020.00694Shen, Y., Fukushima, M., Ito, Y., Muraki, E., Hosono, T., Seki, T., et al. (2010).Verification of the Antidiabetic Effects of Cinnamon (CinnamomumZeylanicum) Using Insulin-Uncontrolled Type 1 Diabetic Rats and CulturedAdipocytes. Biosci. Biotechnol. Biochem. 74, 2418\u20132425. doi:10.1271/bbb.100453Shihabudeen, H. M. S., Priscilla, D. H., and Thirumurugan, K. (2011).Cinnamon Extract Inhibits Alpha-Glucosidase Activity and DampensPostprandial Glucose Excursion in Diabetic Rats. Nutr. Metab. (Lond)8, 46.Shishehbor, F., Rezaeyan Safar, M., Rajaei, E., and Haghighizadeh, M. H. (2018).Cinnamon Consumption Improves Clinical Symptoms and InflammatoryMarkers in Women with Rheumatoid Arthritis. J. Am. Coll. Nutr. 37,685\u2013690. doi:10.1080/07315724.2018.1460733Singh, G., Maurya, S., Delampasona, M. P., and Catalan, C. A. N. (2007). AComparison of Chemical, Antioxidant and Antimicrobial Studies of CinnamonLeaf and Bark Volatile Oils, Oleoresins and Their Constituents. Food Chem.Toxicol. 45, 1650\u20131661. doi:10.1016/j.fct.2007.02.031Skandamis, P. N., and Nychas, G.-J. E. (2001). Effect of Oregano Essential Oil onMicrobiological and Physico-Chemical Attributes of MincedMeat Stored in Airand Modified Atmospheres. J. Appl. Microbiol. 91, 1011\u20131022. doi:10.1046/j.1365-2672.2001.01467.xStalnikowitz, D. K., and Weissbrod, A. B. (2003). Liver Fibrosis and Inflammation.A Review. Ann. Hepatol. 2, 159\u2013163. doi:10.1016/s1665-2681(19)32127-1Subash Babu, P., Prabuseenivasan, S., and Ignacimuthu, S. (2007).Cinnamaldehyde-A Potential Antidiabetic Agent. Phytomedicine 14, 15\u201322.doi:10.1016/j.phymed.2006.11.005Suppapitiporn, S., and Kanpaksi, N. (2006). The Effect of Cinnamon cassia Powderin Type 2 Diabetes Mellitus. J. Med. Assoc. Thai 89 Suppl 3, S200\u2013S205.Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013925Sharifi-Rad et al. Cinnamomum SpeciesTakasao, N., Tsuji-Naito, K., Ishikura, S., Tamura, A., and Akagawa, M. (2012).Cinnamon Extract Promotes Type I Collagen Biosynthesis via Activation ofIGF-I Signaling in Human Dermal Fibroblasts. J. Agric. Food Chem. 60,1193\u20131200. doi:10.1021/jf2043357Talaat, B., and Ammar, I. M. M. (2018). The Added Value of Cinnamon toMetformin in Controlling Symptoms of Polycystic Ovary Syndrome, aRandomized Controlled Trial. Middle East Fertil. Soc. J. 23, 440\u2013445. doi:10.1016/j.mefs.2018.03.005Tao, Y., Xu, X., Yan, J., and Cai, B. (2019). A Sensitive UPLC\u2013MS/MS Method forSimultaneous Determination of Polyphenols in Rat Plasma: Application to aPharmacokinetic Study of Dispensing Granules and Standard Decoction ofCinnamomum cassia Twigs. Biomed. Chromatogr. 33, e4534. doi:10.1002/bmc.4534Thongson, C., Davidson, P. M., Mahakarnchanakul, W., and Weiss, J. (2004).Antimicrobial Activity of Ultrasound-Assisted Solvent-Extracted Spices. Lett.Appl. Microbiol. 39, 401\u2013406. doi:10.1111/j.1472-765x.2004.01605.xTsai, I.-L., Hung, C.-H., Duh, C.-Y., and Chen, I.-S. (2002). Cytotoxic Butanolidesand Secobutanolides from the Stem Wood of Formosan Lindera Communis.Planta Med. 68, 142\u2013145. doi:10.1055/s-2002-20260Tsatsakis, A., Docea, A. O., Calina, D., Tsarouhas, K., Zamfira, L.-M., Mitrut, R.,et al. (2019). A Mechanistic and Pathophysiological Approach for StrokeAssociated with Drugs of Abuse. Jcm 8, 1295. doi:10.3390/jcm8091295Tsuji-Naito, K. (2008). Aldehydic Components of Cinnamon Bark Extract SuppressesRANKL-Induced Osteoclastogenesis through NFATc1 Downregulation. Bioorg.Med. Chem. 16, 9176\u20139183. doi:10.1016/j.bmc.2008.09.036Tung, Y.-T., Yen, P.-L., Lin, C.-Y., and Chang, S.-T. (2010). Anti-inflammatoryActivities of Essential Oils and Their Constituents from Different Provenancesof Indigenous Cinnamon (Cinnamomum Osmophloeum) Leaves. Pharm. Biol.48, 1130\u20131136. doi:10.3109/13880200903527728Turgis, M., Vu, K. D., Dupont, C., and Lacroix, M. (2012). CombinedAntimicrobial Effect of Essential Oils and Bacteriocins against FoodbornePathogens and Food Spoilage Bacteria. Food Res. Int. 48, 696\u2013702. doi:10.1016/j.foodres.2012.06.016Ultee, A., Kets, E. P. W., and Smid, E. J. (1999). Mechanisms of Action of Carvacrolon the Food-Borne Pathogen Bacillus Cereus. Appl. Environ. Microbiol. 65,4606\u20134610. doi:10.1128/aem.65.10.4606-4610.1999Ungureanu, A., Zlatian, O., Mitroi, G., Drocas\u0327, A., T\u0327\u0131\u0302rca\u0306, T., Ca\u0306lina, D., et al. (2017).Staphylococcus aureus Colonisation in Patients from a Primary RegionalHospital. Mol. Med. Rep. 16, 8771\u20138780. doi:10.3892/mmr.2017.7746Unlu, M., Ergene, E., Unlu, G. V., Zeytinoglu, H. S., and Vural, N. (2010).Composition, Antimicrobial Activity and In Vitro Cytotoxicity of EssentialOil from Cinnamomum Zeylanicum Blume (Lauraceae). Food Chem. Toxicol.48, 3274\u20133280. doi:10.1016/j.fct.2010.09.001Utchariyakiat, I., Surassmo, S., Jaturanpinyo, M., Khuntayaporn, P., andChomnawang, M. T. (2016). Efficacy of Cinnamon Bark Oil andCinnamaldehyde on Anti-multidrug Resistant Pseudomonas aeruginosa andthe Synergistic Effects in Combination with Other Antimicrobial Agents. BMCComplement. Altern. Med. 16, 158. doi:10.1186/s12906-016-1134-9Vafa, M., Mohammadi, F., Shidfar, F., Sormaghi, M. S., Heidari, I., Golestan, B.,et al. (2012). Effects of Cinnamon Consumption on Glycemic Status, LipidProfile and Body Composition in Type 2 Diabetic Patients. Int. J. Prev. Med. 3,531\u2013536.Vallianou, N., Tsang, C., Taghizadeh, M., Davoodvandi, A., and Jafarnejad, S. (2019).Effect of Cinnamon (Cinnamomum Zeylanicum) Supplementation on SerumC-Reactive Protein Concentrations: A Meta-Analysis and Systematic Review.Complement. therapies Med. 42, 271\u2013278. doi:10.1016/j.ctim.2018.12.005Vallverd\u00fa-Queralt, A., Regueiro, J., Mart\u00ednez-Hu\u00e9lamo, M., Rinaldi Alvarenga,J. F., Leal, L. N., and Lamuela-Raventos, R. M. (2014). A Comprehensive Studyon the Phenolic Profile of Widely Used Culinary Herbs and Spices: Rosemary,Thyme, Oregano, Cinnamon, Cumin and Bay. Food Chem. 154, 299\u2013307.doi:10.1016/j.foodchem.2013.12.106Vanschoonbeek, K., Thomassen, B. J. W., Senden, J. M., Wodzig, W. K. W. H., andVan Loon, L. J. C. (2006). Cinnamon Supplementation Does Not ImproveGlycemic Control in Postmenopausal Type 2 Diabetes Patients. J. Nutr. 136,977\u2013980. doi:10.1093/jn/136.4.977Verspohl, E. J., Bauer, K., and Neddermann, E. (2005). Antidiabetic EffectofCinnamomum cassia andCinnamomum Zeylanicum In vivo andIn Vitro.Phytother. Res. 19, 203\u2013206. doi:10.1002/ptr.1643Vivas, A. P. M., and Migliari, D. A. (2015). Cinnamon-induced Oral MucosalContact Reaction. Todentj 9, 257\u2013259. doi:10.2174/1874210601509010257Walanj, S., Walanj, A., Mohan, V., and Thakurdesai, P. A. (2014). Efficacy andSafety of the Topical Use of Intranasal Cinnamon Bark Extract in SeasonalAllergic Rhinitis Patients: A Double-Blind Placebo-Controlled Pilot Study.J. Herbal Med. 4, 37\u201347. doi:10.1016/j.hermed.2013.12.002Wang, H.-M., Chen, C.-Y., and Wen, Z.-H. (2011). Identifying MelanogenesisInhibitors from Cinnamomum Subavenium with In Vitro and In VivoScreening Systems by Targeting the Human Tyrosinase. Exp. Dermatol. 20,242\u2013248. doi:10.1111/j.1600-0625.2010.01161.xWang, J., Su, B., Jiang, H., Cui, N., Yu, Z., Yang, Y., et al. (2020). Traditional Uses,Phytochemistry and Pharmacological Activities of the Genus Cinnamomum(Lauraceae): A Review. Fitoterapia 146, 104675. doi:10.1016/j.fitote.2020.104675Wang, R., Wang, R., and Yang, B. (2009). Extraction of Essential Oils from FiveCinnamon Leaves and Identification of Their Volatile CompoundCompositions. Innovative Food Sci. Emerging Tech. 10, 289\u2013292. doi:10.1016/j.ifset.2008.12.002Wannissorn, B., Jarikasem, S., Siriwangchai, T., and Thubthimthed, S. (2005).Antibacterial Properties of Essential Oils from Thai Medicinal Plants.Fitoterapia 76, 233\u2013236. doi:10.1016/j.fitote.2004.12.009Wansi, S. L., Nyadjeu, P., Ngamga, D., Mbuyo, E. P. N., Nguelefack, T. B., andKamanyi, A. (2007). Blood Pressure Lowering Effect of the Ethanol Extractfrom the Stembark of Cinnamomum Zeylanicum (Lauraceae) in Rats.Pharmacol. Online 3, 166\u2013176.Wild, S., Roglic, G., Green, A., Sicree, R., and King, H. (2004). Global Prevalence ofDiabetes: Estimates for the Year 2000 and Projections for 2030. Diabetes Care27, 1047\u20131053. doi:10.2337/diacare.27.5.1047Wiweko, B., and Susanto, C. A. (2017). The Effect of Metformin and Cinnamon onSerum Anti-mullerian Hormone in Women Having PCOS: A Double-Blind,Randomized, Controlled Trial. J. Hum. Reprod. Sci. 10, 31\u201336. doi:10.4103/jhrs.JHRS_90_16Woehrlin, F., Fry, H., Abraham, K., and Preiss-Weigert, A. (2010).Quantification of Flavoring Constituents in Cinnamon: High Variationof Coumarin in cassia Bark from the German Retail Market and inAuthentic Samples from Indonesia. J. Agric. Food Chem. 58,10568\u201310575. doi:10.1021/jf102112pWondrak, G., Villeneuve, N. F., Lamore, S. D., Bause, A. S., Jiang, T., and Zhang, D.D. (2010). The Cinnamon-Derived Dietary Factor Cinnamic AldehydeActivates the Nrf2-dependent Antioxidant Response in Human EpithelialColon Cells. Molecules 15, 3338\u20133355. doi:10.3390/molecules15053338Wu, K., Lin, Y., Chai, X., Duan, X., Zhao, X., and Chun, C. (2019). Mechanisms ofVapor-phase Antibacterial Action of Essential Oil from CinnamomumCamphora Var. Linaloofera Fujita against Escherichia coli. Food Sci. Nutr. 7,2546\u20132555. doi:10.1002/fsn3.1104Wu, V., Qiu, X., Delosreyes, B., Lin, C., and Pan, Y. (2009). Application ofCranberry Concentrate (Vaccinium Macrocarpon) to Control Escherichiacoli O157:H7 in Ground Beef and its Antimicrobial Mechanism Related tothe Downregulated Slp, hdeA and Cfa. FoodMicrobiol. 26, 32\u201338. doi:10.1016/j.fm.2008.07.014Yanakiev, S. (2020). Effects of Cinnamon (Cinnamomum spp.) in Dentistry: AReview. Molecules 25. doi:10.3390/molecules25184184Yang, C.-H., Li, R.-X., and Chuang, L.-Y. (2012). Antioxidant Activity of VariousParts of Cinnamomum cassia Extracted with Different Extraction Methods.Molecules 17, 7294\u20137304. doi:10.3390/molecules17067294Yang, S. Y., Wang, H. M., Wu, T. W., Chen, Y. J., Shieh, J. J., Lin, J. H., et al.(2013). Subamolide B Isolated from Medicinal Plant CinnamomumSubavenium Induces Cytotoxicity in Human Cutaneous Squamous CellCarcinoma Cells through Mitochondrial and CHOP-dependent Cell DeathPathways. Evid. Based Complement. Alternat Med. 2013, 630415. doi:10.1155/2013/630415Yang, Y.-C., Lee, H.-S., Lee, S. H., Clark, J. M., and Ahn, Y.-J. (2005). Ovicidal andAdulticidal Activities of Cinnamomum Zeylanicum Bark Essential OilCompounds and Related Compounds against Pediculus Humanus Capitis(Anoplura: Pediculicidae). Int. J. Parasitol. 35, 1595\u20131600. doi:10.1016/j.ijpara.2005.08.005Yap, P. S. X., Krishnan, T., Chan, K.-G., and Lim, S. H. E. (2015). AntibacterialMode of Action of Cinnamomum Verum Bark Essential Oil, Alone and inFrontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013926Sharifi-Rad et al. Cinnamomum SpeciesCombination with Piperacillin, against a Multi-Drug-Resistant Escherichiacoli Strain. J. Microbiol. Biotechnol. 25, 1299\u20131306. doi:10.4014/jmb.1407.07054Yeh, R.-Y., Shiu, Y.-L., Shei, S.-C., Cheng, S.-C., Huang, S.-Y., Lin, J.-C., et al.(2009). Evaluation of the Antibacterial Activity of Leaf and Twig Extracts ofStout Camphor Tree, Cinnamomum Kanehirae, and the Effects on Immunityand Disease Resistance of White Shrimp, Litopenaeus Vannamei. Fish ShellfishImmunol. 27, 26\u201332. doi:10.1016/j.fsi.2008.11.008Yun, J.-W., You, J.-R., Kim, Y.-S., Kim, S.-H., Cho, E.-Y., Yoon, J.-H., et al. (2018).In vitro and In Vivo Safety Studies of Cinnamon Extract ( Cinnamomum cassia) on General and Genetic Toxicology. Regul. Toxicol. Pharmacol. 95, 115\u2013123.doi:10.1016/j.yrtph.2018.02.017Zhang, J.-H., Liu, L.-Q., He, Y.-L., Kong, W.-J., and Huang, S.-A. (2010). CytotoxicEffect of Trans-cinnamaldehyde on Human Leukemia K562 Cells. ActaPharmacol. Sin 31, 861\u2013866. doi:10.1038/aps.2010.76Zhang,W., Xu, Y.-c., Guo, F.-j., Meng, Y., and Li, M.-l. (2008). Anti-diabetic Effectsof Cinnamaldehyde and Berberine and Their Impacts on Retinol-BindingProtein 4 Expression in Rats with Type 2 Diabetes Mellitus. Chin. Med. J.121, 2124\u20132128. doi:10.1097/00029330-200811010-00003Zhao, J., and Ma, J.-S. (2016). Phytochemicals and Biological Activities of GenusCinnamomum. Res. Rev. J. Pharmacognosy Phytochemistry 4, 27\u201334.Zimmet, P., Alberti, K. G. M. M., and Shaw, J. (2001). Global and SocietalImplications of the Diabetes Epidemic. Nature 414, 782\u2013787. doi:10.1038/414782aZlatian, O., Balasoiu, A. T., Balasoiu, M., Cristea, O., Docea, A. O., Mitrut, R., et al.(2018). Antimicrobial Resistance in Bacterial Pathogens Among HospitalisedPatients with Severe Invasive Infections. Exp. Ther. Med. 16, 4499\u20134510. doi:10.3892/etm.2018.6737Conflict of Interest: The authors declare that the research was conducted in theabsence of any commercial or financial relationships that could be construed as apotential conflict of interest.Copyright \u00a9 2021 Sharifi-Rad, Dey, Koirala, Shaheen, El Omari, Salehi, Goloshvili,Cirone Silva, Bouyahya, Vitalini, Varoni, Martorell, Abdolshahi, Docea, Iriti,Calina, Les, L\u00f3pez and Caruntu. This is an open-access article distributedunder the terms of the Creative Commons Attribution License (CC BY). Theuse, distribution or reproduction in other forums is permitted, provided theoriginal author(s) and the copyright owner(s) are credited and that theoriginal publication in this journal is cited, in accordance with acceptedacademic practice. No use, distribution or reproduction is permitted whichdoes not comply with these terms.Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 60013927Sharifi-Rad et al. Cinnamomum Species"}